ROW_ID,LOCATION,GENDER,CAUSE_OF_DEATH,YEAR,NR_DEATH,AGE_STD_MORTALITY_RATE
1,"Canada, place of residence",Males,"Total, all causes of death  [A00-Y89]",2018,"145,771",810.7
2,"Canada, place of residence",Males,"Total, all causes of death  [A00-Y89]",2019,"146,342",786
3,"Canada, place of residence",Males,"Total, all causes of death  [A00-Y89]",2020,"159,722",832.5
4,"Canada, place of residence",Males,"Total, all causes of death  [A00-Y89]",2021,"163,726",828.3
5,"Canada, place of residence",Males,"Total, all causes of death  [A00-Y89]",2022,"174,065",857.3
6,"Canada, place of residence",Males,Salmonella infections  [A01-A02],2018,4,0
7,"Canada, place of residence",Males,Salmonella infections  [A01-A02],2019,3,0
8,"Canada, place of residence",Males,Salmonella infections  [A01-A02],2020,7,0
9,"Canada, place of residence",Males,Salmonella infections  [A01-A02],2021,7,0
10,"Canada, place of residence",Males,Salmonella infections  [A01-A02],2022,6,0
11,"Canada, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2018,0,0
12,"Canada, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2019,0,0
13,"Canada, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2020,0,0
14,"Canada, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2021,1,0
15,"Canada, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2022,0,0
16,"Canada, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2018,335,1.9
17,"Canada, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2019,311,1.7
18,"Canada, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2020,300,1.6
19,"Canada, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2021,253,1.3
20,"Canada, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2022,290,1.4
21,"Canada, place of residence",Males,Tuberculosis  [A16-A19],2018,49,0.3
22,"Canada, place of residence",Males,Tuberculosis  [A16-A19],2019,51,0.3
23,"Canada, place of residence",Males,Tuberculosis  [A16-A19],2020,58,0.3
24,"Canada, place of residence",Males,Tuberculosis  [A16-A19],2021,67,0.3
25,"Canada, place of residence",Males,Tuberculosis  [A16-A19],2022,69,0.3
26,"Canada, place of residence",Males,Whooping cough  [A37],2018,0,0
27,"Canada, place of residence",Males,Whooping cough  [A37],2019,2,0
28,"Canada, place of residence",Males,Whooping cough  [A37],2020,0,0
29,"Canada, place of residence",Males,Whooping cough  [A37],2021,0,0
30,"Canada, place of residence",Males,Whooping cough  [A37],2022,0,0
31,"Canada, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2018,0,0
32,"Canada, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2019,0,0
33,"Canada, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2020,0,0
34,"Canada, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2021,0,0
35,"Canada, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2022,1,0
36,"Canada, place of residence",Males,Meningococcal infection  [A39],2018,1,0
37,"Canada, place of residence",Males,Meningococcal infection  [A39],2019,3,0
38,"Canada, place of residence",Males,Meningococcal infection  [A39],2020,4,0
39,"Canada, place of residence",Males,Meningococcal infection  [A39],2021,5,0
40,"Canada, place of residence",Males,Meningococcal infection  [A39],2022,3,0
41,"Canada, place of residence",Males,Sepsis  [A40-A41],2018,966,5.5
42,"Canada, place of residence",Males,Sepsis  [A40-A41],2019,985,5.4
43,"Canada, place of residence",Males,Sepsis  [A40-A41],2020,993,5.3
44,"Canada, place of residence",Males,Sepsis  [A40-A41],2021,992,5.1
45,"Canada, place of residence",Males,Sepsis  [A40-A41],2022,"1,020",5.1
46,"Canada, place of residence",Males,Syphilis  [A50-A53],2018,5,0
47,"Canada, place of residence",Males,Syphilis  [A50-A53],2019,2,0
48,"Canada, place of residence",Males,Syphilis  [A50-A53],2020,4,0
49,"Canada, place of residence",Males,Syphilis  [A50-A53],2021,5,0
50,"Canada, place of residence",Males,Syphilis  [A50-A53],2022,4,0
51,"Canada, place of residence",Males,Acute poliomyelitis  [A80],2018,0,0
52,"Canada, place of residence",Males,Acute poliomyelitis  [A80],2019,0,0
53,"Canada, place of residence",Males,Acute poliomyelitis  [A80],2020,0,0
54,"Canada, place of residence",Males,Acute poliomyelitis  [A80],2021,0,0
55,"Canada, place of residence",Males,Acute poliomyelitis  [A80],2022,0,0
56,"Canada, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2018,0,0
57,"Canada, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2019,1,0
58,"Canada, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2020,0,0
59,"Canada, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2021,2,0
60,"Canada, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2022,0,0
61,"Canada, place of residence",Males,Measles  [B05],2018,0,0
62,"Canada, place of residence",Males,Measles  [B05],2019,1,0
63,"Canada, place of residence",Males,Measles  [B05],2020,0,0
64,"Canada, place of residence",Males,Measles  [B05],2021,0,0
65,"Canada, place of residence",Males,Measles  [B05],2022,0,0
66,"Canada, place of residence",Males,Viral hepatitis  [B15-B19],2018,238,1.2
67,"Canada, place of residence",Males,Viral hepatitis  [B15-B19],2019,200,1
68,"Canada, place of residence",Males,Viral hepatitis  [B15-B19],2020,168,0.8
69,"Canada, place of residence",Males,Viral hepatitis  [B15-B19],2021,182,0.9
70,"Canada, place of residence",Males,Viral hepatitis  [B15-B19],2022,144,0.7
71,"Canada, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2018,112,0.6
72,"Canada, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2019,81,0.4
73,"Canada, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2020,111,0.6
74,"Canada, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2021,107,0.6
75,"Canada, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2022,98,0.5
76,"Canada, place of residence",Males,Malaria  [B50-B54],2018,1,0
77,"Canada, place of residence",Males,Malaria  [B50-B54],2019,0,0
78,"Canada, place of residence",Males,Malaria  [B50-B54],2020,0,0
79,"Canada, place of residence",Males,Malaria  [B50-B54],2021,0,0
80,"Canada, place of residence",Males,Malaria  [B50-B54],2022,0,0
81,"Canada, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2018,454,2.5
82,"Canada, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2019,460,2.5
83,"Canada, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2020,463,2.4
84,"Canada, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2021,524,2.6
85,"Canada, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2022,679,3.3
86,"Canada, place of residence",Males,Malignant neoplasms  [C00-C97],2018,"42,216",225.6
87,"Canada, place of residence",Males,Malignant neoplasms  [C00-C97],2019,"42,975",222.1
88,"Canada, place of residence",Males,Malignant neoplasms  [C00-C97],2020,"43,004",215.4
89,"Canada, place of residence",Males,Malignant neoplasms  [C00-C97],2021,"43,890",213.3
90,"Canada, place of residence",Males,Malignant neoplasms  [C00-C97],2022,"43,408",204.8
91,"Canada, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2018,952,5.3
92,"Canada, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2019,988,5.3
93,"Canada, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2020,"1,041",5.5
94,"Canada, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2021,"1,023",5.2
95,"Canada, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2022,"1,004",4.9
96,"Canada, place of residence",Males,Anaemias  [D50-D64],2018,211,1.2
97,"Canada, place of residence",Males,Anaemias  [D50-D64],2019,240,1.4
98,"Canada, place of residence",Males,Anaemias  [D50-D64],2020,258,1.4
99,"Canada, place of residence",Males,Anaemias  [D50-D64],2021,255,1.3
100,"Canada, place of residence",Males,Anaemias  [D50-D64],2022,254,1.3
101,"Canada, place of residence",Males,Diabetes mellitus  [E10-E14],2018,"3,785",20.6
102,"Canada, place of residence",Males,Diabetes mellitus  [E10-E14],2019,"3,934",20.7
103,"Canada, place of residence",Males,Diabetes mellitus  [E10-E14],2020,"4,310",22
104,"Canada, place of residence",Males,Diabetes mellitus  [E10-E14],2021,"4,090",20.4
105,"Canada, place of residence",Males,Diabetes mellitus  [E10-E14],2022,"4,261",20.7
106,"Canada, place of residence",Males,Nutritional deficiencies  [E40-E64],2018,92,0.5
107,"Canada, place of residence",Males,Nutritional deficiencies  [E40-E64],2019,79,0.4
108,"Canada, place of residence",Males,Nutritional deficiencies  [E40-E64],2020,98,0.5
109,"Canada, place of residence",Males,Nutritional deficiencies  [E40-E64],2021,109,0.6
110,"Canada, place of residence",Males,Nutritional deficiencies  [E40-E64],2022,144,0.7
111,"Canada, place of residence",Males,"Dementia  [F010-F019, F03]",2018,"8,338",51.1
112,"Canada, place of residence",Males,"Dementia  [F010-F019, F03]",2019,"8,728",51.2
113,"Canada, place of residence",Males,"Dementia  [F010-F019, F03]",2020,"8,612",48.5
114,"Canada, place of residence",Males,"Dementia  [F010-F019, F03]",2021,"8,696",47.3
115,"Canada, place of residence",Males,"Dementia  [F010-F019, F03]",2022,"9,612",50.7
116,"Canada, place of residence",Males,"Meningitis  [G00, G03]",2018,53,0.3
117,"Canada, place of residence",Males,"Meningitis  [G00, G03]",2019,45,0.2
118,"Canada, place of residence",Males,"Meningitis  [G00, G03]",2020,49,0.3
119,"Canada, place of residence",Males,"Meningitis  [G00, G03]",2021,30,0.2
120,"Canada, place of residence",Males,"Meningitis  [G00, G03]",2022,56,0.3
121,"Canada, place of residence",Males,Parkinson's disease  [G20-G21],2018,"1,868",10.8
122,"Canada, place of residence",Males,Parkinson's disease  [G20-G21],2019,"1,983",11
123,"Canada, place of residence",Males,Parkinson's disease  [G20-G21],2020,"2,130",11.4
124,"Canada, place of residence",Males,Parkinson's disease  [G20-G21],2021,"2,163",11.1
125,"Canada, place of residence",Males,Parkinson's disease  [G20-G21],2022,"2,248",11.2
126,"Canada, place of residence",Males,Alzheimer's disease  [G30],2018,"2,101",12.7
127,"Canada, place of residence",Males,Alzheimer's disease  [G30],2019,"1,998",11.6
128,"Canada, place of residence",Males,Alzheimer's disease  [G30],2020,"1,940",10.8
129,"Canada, place of residence",Males,Alzheimer's disease  [G30],2021,"1,808",9.7
130,"Canada, place of residence",Males,Alzheimer's disease  [G30],2022,"1,754",9
131,"Canada, place of residence",Males,Major cardiovascular diseases  [I00-I78],2018,"37,509",210.9
132,"Canada, place of residence",Males,Major cardiovascular diseases  [I00-I78],2019,"37,308",202.2
133,"Canada, place of residence",Males,Major cardiovascular diseases  [I00-I78],2020,"38,530",201.4
134,"Canada, place of residence",Males,Major cardiovascular diseases  [I00-I78],2021,"39,020",197.9
135,"Canada, place of residence",Males,Major cardiovascular diseases  [I00-I78],2022,"40,466",199.3
136,"Canada, place of residence",Males,Other disorders of circulatory system  [I80-I99],2018,174,0.9
137,"Canada, place of residence",Males,Other disorders of circulatory system  [I80-I99],2019,189,1
138,"Canada, place of residence",Males,Other disorders of circulatory system  [I80-I99],2020,197,1
139,"Canada, place of residence",Males,Other disorders of circulatory system  [I80-I99],2021,215,1.1
140,"Canada, place of residence",Males,Other disorders of circulatory system  [I80-I99],2022,181,0.9
141,"Canada, place of residence",Males,Influenza and pneumonia  [J09-J18],2018,"3,990",23.5
142,"Canada, place of residence",Males,Influenza and pneumonia  [J09-J18],2019,"3,292",18.5
143,"Canada, place of residence",Males,Influenza and pneumonia  [J09-J18],2020,"3,000",16.2
144,"Canada, place of residence",Males,Influenza and pneumonia  [J09-J18],2021,"2,142",11.3
145,"Canada, place of residence",Males,Influenza and pneumonia  [J09-J18],2022,"3,017",15.3
146,"Canada, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2018,55,0.3
147,"Canada, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2019,29,0.2
148,"Canada, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2020,26,0.1
149,"Canada, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2021,10,0.1
150,"Canada, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2022,21,0.1
151,"Canada, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2018,"6,482",36
152,"Canada, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2019,"6,388",34
153,"Canada, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2020,"5,998",30.7
154,"Canada, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2021,"5,639",27.8
155,"Canada, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2022,"6,208",29.5
156,"Canada, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2018,108,0.6
157,"Canada, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2019,105,0.6
158,"Canada, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2020,111,0.6
159,"Canada, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2021,117,0.6
160,"Canada, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2022,102,0.5
161,"Canada, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2018,940,5.6
162,"Canada, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2019,890,5.1
163,"Canada, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2020,976,5.3
164,"Canada, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2021,"1,127",6
165,"Canada, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2022,"1,253",6.4
166,"Canada, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2018,"2,219",12.3
167,"Canada, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2019,"2,184",11.6
168,"Canada, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2020,"2,129",11
169,"Canada, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2021,"2,251",11.2
170,"Canada, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2022,"2,488",12
171,"Canada, place of residence",Males,Peptic ulcer  [K25-K28],2018,228,1.3
172,"Canada, place of residence",Males,Peptic ulcer  [K25-K28],2019,252,1.3
173,"Canada, place of residence",Males,Peptic ulcer  [K25-K28],2020,306,1.6
174,"Canada, place of residence",Males,Peptic ulcer  [K25-K28],2021,319,1.6
175,"Canada, place of residence",Males,Peptic ulcer  [K25-K28],2022,299,1.4
176,"Canada, place of residence",Males,Diseases of appendix  [K35-K38],2018,20,0.1
177,"Canada, place of residence",Males,Diseases of appendix  [K35-K38],2019,23,0.1
178,"Canada, place of residence",Males,Diseases of appendix  [K35-K38],2020,28,0.2
179,"Canada, place of residence",Males,Diseases of appendix  [K35-K38],2021,29,0.1
180,"Canada, place of residence",Males,Diseases of appendix  [K35-K38],2022,37,0.2
181,"Canada, place of residence",Males,Hernia  [K40-K46],2018,202,1.2
182,"Canada, place of residence",Males,Hernia  [K40-K46],2019,219,1.2
183,"Canada, place of residence",Males,Hernia  [K40-K46],2020,189,1
184,"Canada, place of residence",Males,Hernia  [K40-K46],2021,221,1.1
185,"Canada, place of residence",Males,Hernia  [K40-K46],2022,229,1.2
186,"Canada, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2018,"2,256",11.7
187,"Canada, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2019,"2,394",12.1
188,"Canada, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2020,"2,700",13.5
189,"Canada, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2021,"2,923",14.4
190,"Canada, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2022,"2,881",13.9
191,"Canada, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2018,217,1.3
192,"Canada, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2019,227,1.3
193,"Canada, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2020,269,1.4
194,"Canada, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2021,331,1.7
195,"Canada, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2022,313,1.6
196,"Canada, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2018,"1,732",10.1
197,"Canada, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2019,"1,910",10.7
198,"Canada, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2020,"2,042",11
199,"Canada, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2021,"2,016",10.5
200,"Canada, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2022,"2,165",10.9
201,"Canada, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2018,62,0.4
202,"Canada, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2019,67,0.4
203,"Canada, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2020,83,0.4
204,"Canada, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2021,84,0.4
205,"Canada, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2022,90,0.5
206,"Canada, place of residence",Males,Hyperplasia of prostate  [N40],2018,150,0.9
207,"Canada, place of residence",Males,Hyperplasia of prostate  [N40],2019,123,0.7
208,"Canada, place of residence",Males,Hyperplasia of prostate  [N40],2020,188,1.1
209,"Canada, place of residence",Males,Hyperplasia of prostate  [N40],2021,172,0.9
210,"Canada, place of residence",Males,Hyperplasia of prostate  [N40],2022,203,1.1
211,"Canada, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2018,...,...
212,"Canada, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2019,...,...
213,"Canada, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2020,...,...
214,"Canada, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2021,...,...
215,"Canada, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2022,...,...
216,"Canada, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2018,...,...
217,"Canada, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2019,...,...
218,"Canada, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2020,...,...
219,"Canada, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2021,...,...
220,"Canada, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2022,...,...
221,"Canada, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2018,577,3.3
222,"Canada, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2019,587,3.4
223,"Canada, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2020,540,3.1
224,"Canada, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2021,557,3.3
225,"Canada, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2022,518,3
226,"Canada, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2018,563,3.1
227,"Canada, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2019,534,2.9
228,"Canada, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2020,527,2.9
229,"Canada, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2021,485,2.6
230,"Canada, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2022,568,3
231,"Canada, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2018,"2,537",14.1
232,"Canada, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2019,"2,535",13.8
233,"Canada, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2020,"5,076",27
234,"Canada, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2021,"6,637",34.6
235,"Canada, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2022,"10,639",53.9
236,"Canada, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2018,..,..
237,"Canada, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2019,..,..
238,"Canada, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2020,"7,702",41.3
239,"Canada, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2021,"8,098",40.8
240,"Canada, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2022,"10,597",53.2
241,"Canada, place of residence",Males,All other diseases (residual) 26,2018,"10,329",56.9
242,"Canada, place of residence",Males,All other diseases (residual) 26,2019,"10,760",57.3
243,"Canada, place of residence",Males,All other diseases (residual) 26,2020,"11,536",59.5
244,"Canada, place of residence",Males,All other diseases (residual) 26,2021,"11,869",59.7
245,"Canada, place of residence",Males,All other diseases (residual) 26,2022,"12,709",62
246,"Canada, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2018,"9,526",53.4
247,"Canada, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2019,"9,064",49.7
248,"Canada, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2020,"10,156",54.7
249,"Canada, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2021,"11,704",62
250,"Canada, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2022,"10,768",55.8
251,"Canada, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2018,"3,444",18.9
252,"Canada, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2019,"3,481",18.7
253,"Canada, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2020,"3,112",16.5
254,"Canada, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2021,"2,822",14.9
255,"Canada, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2022,"2,688",13.9
256,"Canada, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2018,387,2.1
257,"Canada, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2019,410,2.2
258,"Canada, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2020,438,2.3
259,"Canada, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2021,338,1.8
260,"Canada, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2022,234,1.2
261,"Canada, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2018,16,0.1
262,"Canada, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2019,12,0.1
263,"Canada, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2020,22,0.1
264,"Canada, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2021,10,0.1
265,"Canada, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2022,9,0
266,"Canada, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2018,183,1
267,"Canada, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2019,208,1.1
268,"Canada, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2020,200,1.1
269,"Canada, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2021,254,1.4
270,"Canada, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2022,176,0.9
271,"Canada, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2018,0,0
272,"Canada, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2019,0,0
273,"Canada, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2020,1,0
274,"Canada, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2021,1,0
275,"Canada, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2022,0,0
276,"Canada, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2018,84,0.4
277,"Canada, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2019,81,0.4
278,"Canada, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2020,90,0.5
279,"Canada, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2021,121,0.6
280,"Canada, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2022,149,0.7
281,"Canada, place of residence",Females,"Total, all causes of death  [A00-Y89]",2018,"139,933",568.6
282,"Canada, place of residence",Females,"Total, all causes of death  [A00-Y89]",2019,"138,959",550
283,"Canada, place of residence",Females,"Total, all causes of death  [A00-Y89]",2020,"148,690",575.3
284,"Canada, place of residence",Females,"Total, all causes of death  [A00-Y89]",2021,"147,914",562.7
285,"Canada, place of residence",Females,"Total, all causes of death  [A00-Y89]",2022,"160,016",592.7
286,"Canada, place of residence",Females,Salmonella infections  [A01-A02],2018,3,0
287,"Canada, place of residence",Females,Salmonella infections  [A01-A02],2019,3,0
288,"Canada, place of residence",Females,Salmonella infections  [A01-A02],2020,2,0
289,"Canada, place of residence",Females,Salmonella infections  [A01-A02],2021,4,0
290,"Canada, place of residence",Females,Salmonella infections  [A01-A02],2022,6,0
291,"Canada, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2018,1,0
292,"Canada, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2019,0,0
293,"Canada, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2020,0,0
294,"Canada, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2021,0,0
295,"Canada, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2022,0,0
296,"Canada, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2018,545,2.1
297,"Canada, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2019,495,1.9
298,"Canada, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2020,482,1.8
299,"Canada, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2021,405,1.5
300,"Canada, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2022,482,1.7
301,"Canada, place of residence",Females,Tuberculosis  [A16-A19],2018,35,0.1
302,"Canada, place of residence",Females,Tuberculosis  [A16-A19],2019,20,0.1
303,"Canada, place of residence",Females,Tuberculosis  [A16-A19],2020,41,0.2
304,"Canada, place of residence",Females,Tuberculosis  [A16-A19],2021,43,0.2
305,"Canada, place of residence",Females,Tuberculosis  [A16-A19],2022,50,0.2
306,"Canada, place of residence",Females,Whooping cough  [A37],2018,1,0
307,"Canada, place of residence",Females,Whooping cough  [A37],2019,0,0
308,"Canada, place of residence",Females,Whooping cough  [A37],2020,0,0
309,"Canada, place of residence",Females,Whooping cough  [A37],2021,0,0
310,"Canada, place of residence",Females,Whooping cough  [A37],2022,0,0
311,"Canada, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2018,0,0
312,"Canada, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2019,0,0
313,"Canada, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2020,0,0
314,"Canada, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2021,0,0
315,"Canada, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2022,0,0
316,"Canada, place of residence",Females,Meningococcal infection  [A39],2018,5,0
317,"Canada, place of residence",Females,Meningococcal infection  [A39],2019,6,0
318,"Canada, place of residence",Females,Meningococcal infection  [A39],2020,4,0
319,"Canada, place of residence",Females,Meningococcal infection  [A39],2021,2,0
320,"Canada, place of residence",Females,Meningococcal infection  [A39],2022,3,0
321,"Canada, place of residence",Females,Sepsis  [A40-A41],2018,"1,229",4.9
322,"Canada, place of residence",Females,Sepsis  [A40-A41],2019,"1,154",4.5
323,"Canada, place of residence",Females,Sepsis  [A40-A41],2020,"1,253",4.7
324,"Canada, place of residence",Females,Sepsis  [A40-A41],2021,"1,072",3.9
325,"Canada, place of residence",Females,Sepsis  [A40-A41],2022,"1,163",4.2
326,"Canada, place of residence",Females,Syphilis  [A50-A53],2018,2,0
327,"Canada, place of residence",Females,Syphilis  [A50-A53],2019,1,0
328,"Canada, place of residence",Females,Syphilis  [A50-A53],2020,2,0
329,"Canada, place of residence",Females,Syphilis  [A50-A53],2021,1,0
330,"Canada, place of residence",Females,Syphilis  [A50-A53],2022,0,0
331,"Canada, place of residence",Females,Acute poliomyelitis  [A80],2018,0,0
332,"Canada, place of residence",Females,Acute poliomyelitis  [A80],2019,0,0
333,"Canada, place of residence",Females,Acute poliomyelitis  [A80],2020,0,0
334,"Canada, place of residence",Females,Acute poliomyelitis  [A80],2021,0,0
335,"Canada, place of residence",Females,Acute poliomyelitis  [A80],2022,0,0
336,"Canada, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2018,0,0
337,"Canada, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2019,0,0
338,"Canada, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2020,0,0
339,"Canada, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2021,0,0
340,"Canada, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2022,0,0
341,"Canada, place of residence",Females,Measles  [B05],2018,0,0
342,"Canada, place of residence",Females,Measles  [B05],2019,0,0
343,"Canada, place of residence",Females,Measles  [B05],2020,0,0
344,"Canada, place of residence",Females,Measles  [B05],2021,0,0
345,"Canada, place of residence",Females,Measles  [B05],2022,0,0
346,"Canada, place of residence",Females,Viral hepatitis  [B15-B19],2018,119,0.6
347,"Canada, place of residence",Females,Viral hepatitis  [B15-B19],2019,111,0.5
348,"Canada, place of residence",Females,Viral hepatitis  [B15-B19],2020,94,0.4
349,"Canada, place of residence",Females,Viral hepatitis  [B15-B19],2021,89,0.4
350,"Canada, place of residence",Females,Viral hepatitis  [B15-B19],2022,66,0.3
351,"Canada, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2018,30,0.2
352,"Canada, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2019,24,0.1
353,"Canada, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2020,25,0.1
354,"Canada, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2021,26,0.1
355,"Canada, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2022,31,0.2
356,"Canada, place of residence",Females,Malaria  [B50-B54],2018,0,0
357,"Canada, place of residence",Females,Malaria  [B50-B54],2019,0,0
358,"Canada, place of residence",Females,Malaria  [B50-B54],2020,0,0
359,"Canada, place of residence",Females,Malaria  [B50-B54],2021,0,0
360,"Canada, place of residence",Females,Malaria  [B50-B54],2022,1,0
361,"Canada, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2018,462,1.9
362,"Canada, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2019,462,1.9
363,"Canada, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2020,455,1.7
364,"Canada, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2021,445,1.7
365,"Canada, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2022,658,2.5
366,"Canada, place of residence",Females,Malignant neoplasms  [C00-C97],2018,"37,510",164.4
367,"Canada, place of residence",Females,Malignant neoplasms  [C00-C97],2019,"37,397",159.7
368,"Canada, place of residence",Females,Malignant neoplasms  [C00-C97],2020,"38,238",159.2
369,"Canada, place of residence",Females,Malignant neoplasms  [C00-C97],2021,"38,932",157.7
370,"Canada, place of residence",Females,Malignant neoplasms  [C00-C97],2022,"39,004",154.2
371,"Canada, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2018,800,3.3
372,"Canada, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2019,779,3.1
373,"Canada, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2020,819,3.2
374,"Canada, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2021,770,2.9
375,"Canada, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2022,799,2.9
376,"Canada, place of residence",Females,Anaemias  [D50-D64],2018,312,1.2
377,"Canada, place of residence",Females,Anaemias  [D50-D64],2019,303,1.1
378,"Canada, place of residence",Females,Anaemias  [D50-D64],2020,369,1.3
379,"Canada, place of residence",Females,Anaemias  [D50-D64],2021,397,1.3
380,"Canada, place of residence",Females,Anaemias  [D50-D64],2022,400,1.3
381,"Canada, place of residence",Females,Diabetes mellitus  [E10-E14],2018,"3,079",12.8
382,"Canada, place of residence",Females,Diabetes mellitus  [E10-E14],2019,"3,053",12.4
383,"Canada, place of residence",Females,Diabetes mellitus  [E10-E14],2020,"3,344",13.2
384,"Canada, place of residence",Females,Diabetes mellitus  [E10-E14],2021,"3,382",13
385,"Canada, place of residence",Females,Diabetes mellitus  [E10-E14],2022,"3,296",12.3
386,"Canada, place of residence",Females,Nutritional deficiencies  [E40-E64],2018,158,0.6
387,"Canada, place of residence",Females,Nutritional deficiencies  [E40-E64],2019,138,0.5
388,"Canada, place of residence",Females,Nutritional deficiencies  [E40-E64],2020,156,0.6
389,"Canada, place of residence",Females,Nutritional deficiencies  [E40-E64],2021,165,0.6
390,"Canada, place of residence",Females,Nutritional deficiencies  [E40-E64],2022,177,0.6
391,"Canada, place of residence",Females,"Dementia  [F010-F019, F03]",2018,"14,709",51.9
392,"Canada, place of residence",Females,"Dementia  [F010-F019, F03]",2019,"15,250",52.5
393,"Canada, place of residence",Females,"Dementia  [F010-F019, F03]",2020,"15,024",50.6
394,"Canada, place of residence",Females,"Dementia  [F010-F019, F03]",2021,"14,920",49.2
395,"Canada, place of residence",Females,"Dementia  [F010-F019, F03]",2022,"16,382",53
396,"Canada, place of residence",Females,"Meningitis  [G00, G03]",2018,40,0.2
397,"Canada, place of residence",Females,"Meningitis  [G00, G03]",2019,32,0.2
398,"Canada, place of residence",Females,"Meningitis  [G00, G03]",2020,27,0.1
399,"Canada, place of residence",Females,"Meningitis  [G00, G03]",2021,28,0.1
400,"Canada, place of residence",Females,"Meningitis  [G00, G03]",2022,33,0.1
401,"Canada, place of residence",Females,Parkinson's disease  [G20-G21],2018,"1,236",5
402,"Canada, place of residence",Females,Parkinson's disease  [G20-G21],2019,"1,172",4.6
403,"Canada, place of residence",Females,Parkinson's disease  [G20-G21],2020,"1,328",5.1
404,"Canada, place of residence",Females,Parkinson's disease  [G20-G21],2021,"1,326",4.9
405,"Canada, place of residence",Females,Parkinson's disease  [G20-G21],2022,"1,369",4.9
406,"Canada, place of residence",Females,Alzheimer's disease  [G30],2018,"4,338",15.9
407,"Canada, place of residence",Females,Alzheimer's disease  [G30],2019,"4,183",14.9
408,"Canada, place of residence",Females,Alzheimer's disease  [G30],2020,"3,848",13.3
409,"Canada, place of residence",Females,Alzheimer's disease  [G30],2021,"3,663",12.4
410,"Canada, place of residence",Females,Alzheimer's disease  [G30],2022,"3,659",12.2
411,"Canada, place of residence",Females,Major cardiovascular diseases  [I00-I78],2018,"34,998",134.5
412,"Canada, place of residence",Females,Major cardiovascular diseases  [I00-I78],2019,"34,727",129.8
413,"Canada, place of residence",Females,Major cardiovascular diseases  [I00-I78],2020,"34,991",128.2
414,"Canada, place of residence",Females,Major cardiovascular diseases  [I00-I78],2021,"34,998",125
415,"Canada, place of residence",Females,Major cardiovascular diseases  [I00-I78],2022,"36,173",126.7
416,"Canada, place of residence",Females,Other disorders of circulatory system  [I80-I99],2018,180,0.8
417,"Canada, place of residence",Females,Other disorders of circulatory system  [I80-I99],2019,212,0.9
418,"Canada, place of residence",Females,Other disorders of circulatory system  [I80-I99],2020,222,0.9
419,"Canada, place of residence",Females,Other disorders of circulatory system  [I80-I99],2021,204,0.9
420,"Canada, place of residence",Females,Other disorders of circulatory system  [I80-I99],2022,224,0.9
421,"Canada, place of residence",Females,Influenza and pneumonia  [J09-J18],2018,"4,604",17.2
422,"Canada, place of residence",Females,Influenza and pneumonia  [J09-J18],2019,"3,653",13.5
423,"Canada, place of residence",Females,Influenza and pneumonia  [J09-J18],2020,"3,037",11
424,"Canada, place of residence",Females,Influenza and pneumonia  [J09-J18],2021,"1,973",6.9
425,"Canada, place of residence",Females,Influenza and pneumonia  [J09-J18],2022,"2,968",10.4
426,"Canada, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2018,90,0.3
427,"Canada, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2019,46,0.2
428,"Canada, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2020,44,0.2
429,"Canada, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2021,18,0.1
430,"Canada, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2022,28,0.1
431,"Canada, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2018,"6,588",27.1
432,"Canada, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2019,"6,514",26
433,"Canada, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2020,"5,846",22.7
434,"Canada, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2021,"5,379",20.3
435,"Canada, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2022,"6,254",23.1
436,"Canada, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2018,6,0
437,"Canada, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2019,5,0
438,"Canada, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2020,8,0
439,"Canada, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2021,10,0
440,"Canada, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2022,7,0
441,"Canada, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2018,676,2.5
442,"Canada, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2019,683,2.5
443,"Canada, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2020,710,2.5
444,"Canada, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2021,785,2.7
445,"Canada, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2022,851,2.9
446,"Canada, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2018,"1,709",7
447,"Canada, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2019,"1,798",7.1
448,"Canada, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2020,"1,675",6.5
449,"Canada, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2021,"1,586",6
450,"Canada, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2022,"1,841",6.9
451,"Canada, place of residence",Females,Peptic ulcer  [K25-K28],2018,215,0.9
452,"Canada, place of residence",Females,Peptic ulcer  [K25-K28],2019,238,0.9
453,"Canada, place of residence",Females,Peptic ulcer  [K25-K28],2020,249,0.9
454,"Canada, place of residence",Females,Peptic ulcer  [K25-K28],2021,256,1
455,"Canada, place of residence",Females,Peptic ulcer  [K25-K28],2022,262,1
456,"Canada, place of residence",Females,Diseases of appendix  [K35-K38],2018,20,0.1
457,"Canada, place of residence",Females,Diseases of appendix  [K35-K38],2019,24,0.1
458,"Canada, place of residence",Females,Diseases of appendix  [K35-K38],2020,20,0.1
459,"Canada, place of residence",Females,Diseases of appendix  [K35-K38],2021,28,0.1
460,"Canada, place of residence",Females,Diseases of appendix  [K35-K38],2022,27,0.1
461,"Canada, place of residence",Females,Hernia  [K40-K46],2018,221,0.9
462,"Canada, place of residence",Females,Hernia  [K40-K46],2019,227,0.9
463,"Canada, place of residence",Females,Hernia  [K40-K46],2020,240,0.9
464,"Canada, place of residence",Females,Hernia  [K40-K46],2021,243,0.9
465,"Canada, place of residence",Females,Hernia  [K40-K46],2022,269,1
466,"Canada, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2018,"1,317",6.3
467,"Canada, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2019,"1,314",6.1
468,"Canada, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2020,"1,499",7
469,"Canada, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2021,"1,694",7.7
470,"Canada, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2022,"1,649",7.3
471,"Canada, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2018,240,0.9
472,"Canada, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2019,261,1
473,"Canada, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2020,242,0.9
474,"Canada, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2021,298,1.1
475,"Canada, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2022,252,0.9
476,"Canada, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2018,"1,881",7.3
477,"Canada, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2019,"1,860",7
478,"Canada, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2020,"2,023",7.5
479,"Canada, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2021,"1,962",7
480,"Canada, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2022,"2,069",7.3
481,"Canada, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2018,101,0.4
482,"Canada, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2019,101,0.4
483,"Canada, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2020,105,0.4
484,"Canada, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2021,119,0.4
485,"Canada, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2022,117,0.4
486,"Canada, place of residence",Females,Hyperplasia of prostate  [N40],2018,...,...
487,"Canada, place of residence",Females,Hyperplasia of prostate  [N40],2019,...,...
488,"Canada, place of residence",Females,Hyperplasia of prostate  [N40],2020,...,...
489,"Canada, place of residence",Females,Hyperplasia of prostate  [N40],2021,...,...
490,"Canada, place of residence",Females,Hyperplasia of prostate  [N40],2022,...,...
491,"Canada, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2018,17,0.1
492,"Canada, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2019,20,0.1
493,"Canada, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2020,26,0.1
494,"Canada, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2021,41,0.2
495,"Canada, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2022,34,0.1
496,"Canada, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2018,34,0.2
497,"Canada, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2019,32,0.2
498,"Canada, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2020,34,0.2
499,"Canada, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2021,30,0.2
500,"Canada, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2022,30,0.2
501,"Canada, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2018,456,2.7
502,"Canada, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2019,422,2.5
503,"Canada, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2020,399,2.4
504,"Canada, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2021,407,2.5
505,"Canada, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2022,441,2.7
506,"Canada, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2018,521,2.8
507,"Canada, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2019,475,2.5
508,"Canada, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2020,533,2.8
509,"Canada, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2021,445,2.3
510,"Canada, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2022,469,2.4
511,"Canada, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2018,"2,298",9.7
512,"Canada, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2019,"2,294",9.2
513,"Canada, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2020,"3,152",13.3
514,"Canada, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2021,"4,259",18
515,"Canada, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2022,"7,055",29.3
516,"Canada, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2018,..,..
517,"Canada, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2019,..,..
518,"Canada, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2020,"8,188",29.4
519,"Canada, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2021,"6,368",24.2
520,"Canada, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2022,"9,119",32.1
521,"Canada, place of residence",Females,All other diseases (residual) 26,2018,"11,381",47.1
522,"Canada, place of residence",Females,All other diseases (residual) 26,2019,"11,588",46.8
523,"Canada, place of residence",Females,All other diseases (residual) 26,2020,"11,909",47.3
524,"Canada, place of residence",Females,All other diseases (residual) 26,2021,"12,356",47.8
525,"Canada, place of residence",Females,All other diseases (residual) 26,2022,"13,496",50.6
526,"Canada, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2018,"6,329",27.2
527,"Canada, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2019,"6,463",27
528,"Canada, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2020,"6,662",27.4
529,"Canada, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2021,"7,553",31
530,"Canada, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2022,"7,597",29.5
531,"Canada, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2018,"1,132",6.2
532,"Canada, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2019,"1,100",5.9
533,"Canada, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2020,"1,040",5.5
534,"Canada, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2021,947,5
535,"Canada, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2022,905,4.7
536,"Canada, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2018,130,0.7
537,"Canada, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2019,121,0.6
538,"Canada, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2020,121,0.6
539,"Canada, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2021,93,0.5
540,"Canada, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2022,72,0.4
541,"Canada, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2018,2,0
542,"Canada, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2019,2,0
543,"Canada, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2020,0,0
544,"Canada, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2021,1,0
545,"Canada, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2022,0,0
546,"Canada, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2018,89,0.5
547,"Canada, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2019,115,0.6
548,"Canada, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2020,125,0.6
549,"Canada, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2021,106,0.5
550,"Canada, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2022,94,0.5
551,"Canada, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2018,0,0
552,"Canada, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2019,0,0
553,"Canada, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2020,0,0
554,"Canada, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2021,0,0
555,"Canada, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2022,0,0
556,"Canada, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2018,84,0.4
557,"Canada, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2019,81,0.3
558,"Canada, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2020,79,0.3
559,"Canada, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2021,84,0.3
560,"Canada, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2022,130,0.5
561,"Newfoundland and Labrador, place of residence",Males,"Total, all causes of death  [A00-Y89]",2018,"2,689",973.8
562,"Newfoundland and Labrador, place of residence",Males,"Total, all causes of death  [A00-Y89]",2019,"2,800",979.7
563,"Newfoundland and Labrador, place of residence",Males,"Total, all causes of death  [A00-Y89]",2020,"2,867",977.3
564,"Newfoundland and Labrador, place of residence",Males,"Total, all causes of death  [A00-Y89]",2021,"3,055","1,002.30"
565,"Newfoundland and Labrador, place of residence",Males,"Total, all causes of death  [A00-Y89]",2022,"3,380","1,066.80"
566,"Newfoundland and Labrador, place of residence",Males,Salmonella infections  [A01-A02],2018,0,0
567,"Newfoundland and Labrador, place of residence",Males,Salmonella infections  [A01-A02],2019,0,0
568,"Newfoundland and Labrador, place of residence",Males,Salmonella infections  [A01-A02],2020,0,0
569,"Newfoundland and Labrador, place of residence",Males,Salmonella infections  [A01-A02],2021,0,0
570,"Newfoundland and Labrador, place of residence",Males,Salmonella infections  [A01-A02],2022,0,0
571,"Newfoundland and Labrador, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2018,0,0
572,"Newfoundland and Labrador, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2019,0,0
573,"Newfoundland and Labrador, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2020,0,0
574,"Newfoundland and Labrador, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2021,0,0
575,"Newfoundland and Labrador, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2022,0,0
576,"Newfoundland and Labrador, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2018,5,1.5
577,"Newfoundland and Labrador, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2019,4,1.7
578,"Newfoundland and Labrador, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2020,5,1.6
579,"Newfoundland and Labrador, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2021,8,2.9
580,"Newfoundland and Labrador, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2022,3,0.8
581,"Newfoundland and Labrador, place of residence",Males,Tuberculosis  [A16-A19],2018,1,0.4
582,"Newfoundland and Labrador, place of residence",Males,Tuberculosis  [A16-A19],2019,0,0
583,"Newfoundland and Labrador, place of residence",Males,Tuberculosis  [A16-A19],2020,0,0
584,"Newfoundland and Labrador, place of residence",Males,Tuberculosis  [A16-A19],2021,0,0
585,"Newfoundland and Labrador, place of residence",Males,Tuberculosis  [A16-A19],2022,0,0
586,"Newfoundland and Labrador, place of residence",Males,Whooping cough  [A37],2018,0,0
587,"Newfoundland and Labrador, place of residence",Males,Whooping cough  [A37],2019,0,0
588,"Newfoundland and Labrador, place of residence",Males,Whooping cough  [A37],2020,0,0
589,"Newfoundland and Labrador, place of residence",Males,Whooping cough  [A37],2021,0,0
590,"Newfoundland and Labrador, place of residence",Males,Whooping cough  [A37],2022,0,0
591,"Newfoundland and Labrador, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2018,0,0
592,"Newfoundland and Labrador, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2019,0,0
593,"Newfoundland and Labrador, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2020,0,0
594,"Newfoundland and Labrador, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2021,0,0
595,"Newfoundland and Labrador, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2022,0,0
596,"Newfoundland and Labrador, place of residence",Males,Meningococcal infection  [A39],2018,0,0
597,"Newfoundland and Labrador, place of residence",Males,Meningococcal infection  [A39],2019,0,0
598,"Newfoundland and Labrador, place of residence",Males,Meningococcal infection  [A39],2020,0,0
599,"Newfoundland and Labrador, place of residence",Males,Meningococcal infection  [A39],2021,0,0
600,"Newfoundland and Labrador, place of residence",Males,Meningococcal infection  [A39],2022,0,0
601,"Newfoundland and Labrador, place of residence",Males,Sepsis  [A40-A41],2018,19,6.3
602,"Newfoundland and Labrador, place of residence",Males,Sepsis  [A40-A41],2019,15,5.8
603,"Newfoundland and Labrador, place of residence",Males,Sepsis  [A40-A41],2020,23,7.2
604,"Newfoundland and Labrador, place of residence",Males,Sepsis  [A40-A41],2021,31,10
605,"Newfoundland and Labrador, place of residence",Males,Sepsis  [A40-A41],2022,18,6.2
606,"Newfoundland and Labrador, place of residence",Males,Syphilis  [A50-A53],2018,0,0
607,"Newfoundland and Labrador, place of residence",Males,Syphilis  [A50-A53],2019,0,0
608,"Newfoundland and Labrador, place of residence",Males,Syphilis  [A50-A53],2020,0,0
609,"Newfoundland and Labrador, place of residence",Males,Syphilis  [A50-A53],2021,0,0
610,"Newfoundland and Labrador, place of residence",Males,Syphilis  [A50-A53],2022,0,0
611,"Newfoundland and Labrador, place of residence",Males,Acute poliomyelitis  [A80],2018,0,0
612,"Newfoundland and Labrador, place of residence",Males,Acute poliomyelitis  [A80],2019,0,0
613,"Newfoundland and Labrador, place of residence",Males,Acute poliomyelitis  [A80],2020,0,0
614,"Newfoundland and Labrador, place of residence",Males,Acute poliomyelitis  [A80],2021,0,0
615,"Newfoundland and Labrador, place of residence",Males,Acute poliomyelitis  [A80],2022,0,0
616,"Newfoundland and Labrador, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2018,0,0
617,"Newfoundland and Labrador, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2019,0,0
618,"Newfoundland and Labrador, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2020,0,0
619,"Newfoundland and Labrador, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2021,0,0
620,"Newfoundland and Labrador, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2022,0,0
621,"Newfoundland and Labrador, place of residence",Males,Measles  [B05],2018,0,0
622,"Newfoundland and Labrador, place of residence",Males,Measles  [B05],2019,0,0
623,"Newfoundland and Labrador, place of residence",Males,Measles  [B05],2020,0,0
624,"Newfoundland and Labrador, place of residence",Males,Measles  [B05],2021,0,0
625,"Newfoundland and Labrador, place of residence",Males,Measles  [B05],2022,0,0
626,"Newfoundland and Labrador, place of residence",Males,Viral hepatitis  [B15-B19],2018,1,0.4
627,"Newfoundland and Labrador, place of residence",Males,Viral hepatitis  [B15-B19],2019,1,0.2
628,"Newfoundland and Labrador, place of residence",Males,Viral hepatitis  [B15-B19],2020,1,0.2
629,"Newfoundland and Labrador, place of residence",Males,Viral hepatitis  [B15-B19],2021,3,1.2
630,"Newfoundland and Labrador, place of residence",Males,Viral hepatitis  [B15-B19],2022,2,0.8
631,"Newfoundland and Labrador, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2018,0,0
632,"Newfoundland and Labrador, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2019,2,0.7
633,"Newfoundland and Labrador, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2020,0,0
634,"Newfoundland and Labrador, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2021,2,0.7
635,"Newfoundland and Labrador, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2022,1,0.4
636,"Newfoundland and Labrador, place of residence",Males,Malaria  [B50-B54],2018,0,0
637,"Newfoundland and Labrador, place of residence",Males,Malaria  [B50-B54],2019,0,0
638,"Newfoundland and Labrador, place of residence",Males,Malaria  [B50-B54],2020,0,0
639,"Newfoundland and Labrador, place of residence",Males,Malaria  [B50-B54],2021,0,0
640,"Newfoundland and Labrador, place of residence",Males,Malaria  [B50-B54],2022,0,0
641,"Newfoundland and Labrador, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2018,5,2
642,"Newfoundland and Labrador, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2019,3,0.9
643,"Newfoundland and Labrador, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2020,11,3.7
644,"Newfoundland and Labrador, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2021,10,3.3
645,"Newfoundland and Labrador, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2022,8,3.1
646,"Newfoundland and Labrador, place of residence",Males,Malignant neoplasms  [C00-C97],2018,778,258.7
647,"Newfoundland and Labrador, place of residence",Males,Malignant neoplasms  [C00-C97],2019,849,274.6
648,"Newfoundland and Labrador, place of residence",Males,Malignant neoplasms  [C00-C97],2020,875,270.5
649,"Newfoundland and Labrador, place of residence",Males,Malignant neoplasms  [C00-C97],2021,920,279.4
650,"Newfoundland and Labrador, place of residence",Males,Malignant neoplasms  [C00-C97],2022,784,227.5
651,"Newfoundland and Labrador, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2018,23,7.8
652,"Newfoundland and Labrador, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2019,14,5
653,"Newfoundland and Labrador, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2020,14,5.1
654,"Newfoundland and Labrador, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2021,19,5.7
655,"Newfoundland and Labrador, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2022,23,6.9
656,"Newfoundland and Labrador, place of residence",Males,Anaemias  [D50-D64],2018,3,1.3
657,"Newfoundland and Labrador, place of residence",Males,Anaemias  [D50-D64],2019,7,2.7
658,"Newfoundland and Labrador, place of residence",Males,Anaemias  [D50-D64],2020,4,1.5
659,"Newfoundland and Labrador, place of residence",Males,Anaemias  [D50-D64],2021,1,0.2
660,"Newfoundland and Labrador, place of residence",Males,Anaemias  [D50-D64],2022,5,1.7
661,"Newfoundland and Labrador, place of residence",Males,Diabetes mellitus  [E10-E14],2018,99,34.4
662,"Newfoundland and Labrador, place of residence",Males,Diabetes mellitus  [E10-E14],2019,114,38.3
663,"Newfoundland and Labrador, place of residence",Males,Diabetes mellitus  [E10-E14],2020,150,51.3
664,"Newfoundland and Labrador, place of residence",Males,Diabetes mellitus  [E10-E14],2021,127,41.6
665,"Newfoundland and Labrador, place of residence",Males,Diabetes mellitus  [E10-E14],2022,124,38.2
666,"Newfoundland and Labrador, place of residence",Males,Nutritional deficiencies  [E40-E64],2018,2,0.5
667,"Newfoundland and Labrador, place of residence",Males,Nutritional deficiencies  [E40-E64],2019,1,0.3
668,"Newfoundland and Labrador, place of residence",Males,Nutritional deficiencies  [E40-E64],2020,1,0.2
669,"Newfoundland and Labrador, place of residence",Males,Nutritional deficiencies  [E40-E64],2021,2,0.8
670,"Newfoundland and Labrador, place of residence",Males,Nutritional deficiencies  [E40-E64],2022,0,0
671,"Newfoundland and Labrador, place of residence",Males,"Dementia  [F010-F019, F03]",2018,140,58.9
672,"Newfoundland and Labrador, place of residence",Males,"Dementia  [F010-F019, F03]",2019,180,74.4
673,"Newfoundland and Labrador, place of residence",Males,"Dementia  [F010-F019, F03]",2020,145,55.5
674,"Newfoundland and Labrador, place of residence",Males,"Dementia  [F010-F019, F03]",2021,176,67.2
675,"Newfoundland and Labrador, place of residence",Males,"Dementia  [F010-F019, F03]",2022,157,54.9
676,"Newfoundland and Labrador, place of residence",Males,"Meningitis  [G00, G03]",2018,0,0
677,"Newfoundland and Labrador, place of residence",Males,"Meningitis  [G00, G03]",2019,0,0
678,"Newfoundland and Labrador, place of residence",Males,"Meningitis  [G00, G03]",2020,1,0.3
679,"Newfoundland and Labrador, place of residence",Males,"Meningitis  [G00, G03]",2021,1,0.4
680,"Newfoundland and Labrador, place of residence",Males,"Meningitis  [G00, G03]",2022,2,0.7
681,"Newfoundland and Labrador, place of residence",Males,Parkinson's disease  [G20-G21],2018,27,9.4
682,"Newfoundland and Labrador, place of residence",Males,Parkinson's disease  [G20-G21],2019,35,11.4
683,"Newfoundland and Labrador, place of residence",Males,Parkinson's disease  [G20-G21],2020,39,13.1
684,"Newfoundland and Labrador, place of residence",Males,Parkinson's disease  [G20-G21],2021,29,9.1
685,"Newfoundland and Labrador, place of residence",Males,Parkinson's disease  [G20-G21],2022,38,11.9
686,"Newfoundland and Labrador, place of residence",Males,Alzheimer's disease  [G30],2018,24,9.7
687,"Newfoundland and Labrador, place of residence",Males,Alzheimer's disease  [G30],2019,14,5.3
688,"Newfoundland and Labrador, place of residence",Males,Alzheimer's disease  [G30],2020,16,5.7
689,"Newfoundland and Labrador, place of residence",Males,Alzheimer's disease  [G30],2021,12,3.9
690,"Newfoundland and Labrador, place of residence",Males,Alzheimer's disease  [G30],2022,25,8
691,"Newfoundland and Labrador, place of residence",Males,Major cardiovascular diseases  [I00-I78],2018,759,275.9
692,"Newfoundland and Labrador, place of residence",Males,Major cardiovascular diseases  [I00-I78],2019,754,264.2
693,"Newfoundland and Labrador, place of residence",Males,Major cardiovascular diseases  [I00-I78],2020,783,273.3
694,"Newfoundland and Labrador, place of residence",Males,Major cardiovascular diseases  [I00-I78],2021,798,260
695,"Newfoundland and Labrador, place of residence",Males,Major cardiovascular diseases  [I00-I78],2022,722,223.2
696,"Newfoundland and Labrador, place of residence",Males,Other disorders of circulatory system  [I80-I99],2018,1,0.2
697,"Newfoundland and Labrador, place of residence",Males,Other disorders of circulatory system  [I80-I99],2019,2,0.7
698,"Newfoundland and Labrador, place of residence",Males,Other disorders of circulatory system  [I80-I99],2020,0,0
699,"Newfoundland and Labrador, place of residence",Males,Other disorders of circulatory system  [I80-I99],2021,5,1.4
700,"Newfoundland and Labrador, place of residence",Males,Other disorders of circulatory system  [I80-I99],2022,2,0.6
701,"Newfoundland and Labrador, place of residence",Males,Influenza and pneumonia  [J09-J18],2018,70,31.3
702,"Newfoundland and Labrador, place of residence",Males,Influenza and pneumonia  [J09-J18],2019,70,28
703,"Newfoundland and Labrador, place of residence",Males,Influenza and pneumonia  [J09-J18],2020,33,12.1
704,"Newfoundland and Labrador, place of residence",Males,Influenza and pneumonia  [J09-J18],2021,29,11.5
705,"Newfoundland and Labrador, place of residence",Males,Influenza and pneumonia  [J09-J18],2022,35,11.9
706,"Newfoundland and Labrador, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2018,2,0.9
707,"Newfoundland and Labrador, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2019,2,0.4
708,"Newfoundland and Labrador, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2020,0,0
709,"Newfoundland and Labrador, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2021,1,0.4
710,"Newfoundland and Labrador, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2022,1,0.3
711,"Newfoundland and Labrador, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2018,146,51.7
712,"Newfoundland and Labrador, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2019,164,58.6
713,"Newfoundland and Labrador, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2020,132,44.3
714,"Newfoundland and Labrador, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2021,113,35.3
715,"Newfoundland and Labrador, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2022,143,44.5
716,"Newfoundland and Labrador, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2018,0,0
717,"Newfoundland and Labrador, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2019,2,1
718,"Newfoundland and Labrador, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2020,1,0.4
719,"Newfoundland and Labrador, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2021,0,0
720,"Newfoundland and Labrador, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2022,0,0
721,"Newfoundland and Labrador, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2018,16,7.1
722,"Newfoundland and Labrador, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2019,7,2.9
723,"Newfoundland and Labrador, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2020,15,6.2
724,"Newfoundland and Labrador, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2021,16,5.5
725,"Newfoundland and Labrador, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2022,18,6.7
726,"Newfoundland and Labrador, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2018,47,16.3
727,"Newfoundland and Labrador, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2019,43,13.5
728,"Newfoundland and Labrador, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2020,24,8.4
729,"Newfoundland and Labrador, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2021,38,12
730,"Newfoundland and Labrador, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2022,45,13.4
731,"Newfoundland and Labrador, place of residence",Males,Peptic ulcer  [K25-K28],2018,0,0
732,"Newfoundland and Labrador, place of residence",Males,Peptic ulcer  [K25-K28],2019,3,0.9
733,"Newfoundland and Labrador, place of residence",Males,Peptic ulcer  [K25-K28],2020,1,0.3
734,"Newfoundland and Labrador, place of residence",Males,Peptic ulcer  [K25-K28],2021,1,0.2
735,"Newfoundland and Labrador, place of residence",Males,Peptic ulcer  [K25-K28],2022,6,2.2
736,"Newfoundland and Labrador, place of residence",Males,Diseases of appendix  [K35-K38],2018,1,0.6
737,"Newfoundland and Labrador, place of residence",Males,Diseases of appendix  [K35-K38],2019,0,0
738,"Newfoundland and Labrador, place of residence",Males,Diseases of appendix  [K35-K38],2020,0,0
739,"Newfoundland and Labrador, place of residence",Males,Diseases of appendix  [K35-K38],2021,0,0
740,"Newfoundland and Labrador, place of residence",Males,Diseases of appendix  [K35-K38],2022,0,0
741,"Newfoundland and Labrador, place of residence",Males,Hernia  [K40-K46],2018,4,1.4
742,"Newfoundland and Labrador, place of residence",Males,Hernia  [K40-K46],2019,3,1.2
743,"Newfoundland and Labrador, place of residence",Males,Hernia  [K40-K46],2020,3,1
744,"Newfoundland and Labrador, place of residence",Males,Hernia  [K40-K46],2021,2,0.5
745,"Newfoundland and Labrador, place of residence",Males,Hernia  [K40-K46],2022,5,2
746,"Newfoundland and Labrador, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2018,34,10.7
747,"Newfoundland and Labrador, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2019,48,16.1
748,"Newfoundland and Labrador, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2020,56,17.6
749,"Newfoundland and Labrador, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2021,57,17.1
750,"Newfoundland and Labrador, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2022,51,14.6
751,"Newfoundland and Labrador, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2018,4,1.7
752,"Newfoundland and Labrador, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2019,6,2.2
753,"Newfoundland and Labrador, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2020,4,1
754,"Newfoundland and Labrador, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2021,6,2.1
755,"Newfoundland and Labrador, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2022,9,2.7
756,"Newfoundland and Labrador, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2018,47,18.2
757,"Newfoundland and Labrador, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2019,44,16.9
758,"Newfoundland and Labrador, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2020,59,20
759,"Newfoundland and Labrador, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2021,64,21.5
760,"Newfoundland and Labrador, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2022,56,17.8
761,"Newfoundland and Labrador, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2018,0,0
762,"Newfoundland and Labrador, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2019,2,0.5
763,"Newfoundland and Labrador, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2020,1,0.4
764,"Newfoundland and Labrador, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2021,0,0
765,"Newfoundland and Labrador, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2022,1,0.3
766,"Newfoundland and Labrador, place of residence",Males,Hyperplasia of prostate  [N40],2018,2,1.3
767,"Newfoundland and Labrador, place of residence",Males,Hyperplasia of prostate  [N40],2019,1,0.6
768,"Newfoundland and Labrador, place of residence",Males,Hyperplasia of prostate  [N40],2020,4,1.7
769,"Newfoundland and Labrador, place of residence",Males,Hyperplasia of prostate  [N40],2021,1,0.3
770,"Newfoundland and Labrador, place of residence",Males,Hyperplasia of prostate  [N40],2022,2,0.8
771,"Newfoundland and Labrador, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2018,...,...
772,"Newfoundland and Labrador, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2019,...,...
773,"Newfoundland and Labrador, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2020,...,...
774,"Newfoundland and Labrador, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2021,...,...
775,"Newfoundland and Labrador, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2022,...,...
776,"Newfoundland and Labrador, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2018,...,...
777,"Newfoundland and Labrador, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2019,...,...
778,"Newfoundland and Labrador, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2020,...,...
779,"Newfoundland and Labrador, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2021,...,...
780,"Newfoundland and Labrador, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2022,...,...
781,"Newfoundland and Labrador, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2018,13,7
782,"Newfoundland and Labrador, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2019,9,5
783,"Newfoundland and Labrador, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2020,8,4.6
784,"Newfoundland and Labrador, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2021,8,4.6
785,"Newfoundland and Labrador, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2022,3,1.7
786,"Newfoundland and Labrador, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2018,15,5.8
787,"Newfoundland and Labrador, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2019,10,3.9
788,"Newfoundland and Labrador, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2020,12,4.6
789,"Newfoundland and Labrador, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2021,8,3.1
790,"Newfoundland and Labrador, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2022,15,5.2
791,"Newfoundland and Labrador, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2018,47,20.5
792,"Newfoundland and Labrador, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2019,58,22.7
793,"Newfoundland and Labrador, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2020,56,21
794,"Newfoundland and Labrador, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2021,86,34.4
795,"Newfoundland and Labrador, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2022,523,171.8
796,"Newfoundland and Labrador, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2018,..,..
797,"Newfoundland and Labrador, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2019,..,..
798,"Newfoundland and Labrador, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2020,3,0.7
799,"Newfoundland and Labrador, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2021,11,3.3
800,"Newfoundland and Labrador, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2022,162,57
801,"Newfoundland and Labrador, place of residence",Males,All other diseases (residual) 26,2018,183,65.5
802,"Newfoundland and Labrador, place of residence",Males,All other diseases (residual) 26,2019,186,63.8
803,"Newfoundland and Labrador, place of residence",Males,All other diseases (residual) 26,2020,203,70.7
804,"Newfoundland and Labrador, place of residence",Males,All other diseases (residual) 26,2021,261,85.3
805,"Newfoundland and Labrador, place of residence",Males,All other diseases (residual) 26,2022,215,64.4
806,"Newfoundland and Labrador, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2018,101,39.2
807,"Newfoundland and Labrador, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2019,95,34.1
808,"Newfoundland and Labrador, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2020,126,50.3
809,"Newfoundland and Labrador, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2021,135,49.1
810,"Newfoundland and Labrador, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2022,113,42.7
811,"Newfoundland and Labrador, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2018,60,23.5
812,"Newfoundland and Labrador, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2019,44,18.1
813,"Newfoundland and Labrador, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2020,46,17.3
814,"Newfoundland and Labrador, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2021,61,23.2
815,"Newfoundland and Labrador, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2022,54,18.7
816,"Newfoundland and Labrador, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2018,3,1.3
817,"Newfoundland and Labrador, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2019,3,1.4
818,"Newfoundland and Labrador, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2020,4,1.8
819,"Newfoundland and Labrador, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2021,4,1.9
820,"Newfoundland and Labrador, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2022,2,0.7
821,"Newfoundland and Labrador, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2018,0,0
822,"Newfoundland and Labrador, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2019,0,0
823,"Newfoundland and Labrador, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2020,0,0
824,"Newfoundland and Labrador, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2021,0,0
825,"Newfoundland and Labrador, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2022,0,0
826,"Newfoundland and Labrador, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2018,5,1.6
827,"Newfoundland and Labrador, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2019,3,1
828,"Newfoundland and Labrador, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2020,6,2.7
829,"Newfoundland and Labrador, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2021,2,0.7
830,"Newfoundland and Labrador, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2022,4,1.9
831,"Newfoundland and Labrador, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2018,0,0
832,"Newfoundland and Labrador, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2019,0,0
833,"Newfoundland and Labrador, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2020,0,0
834,"Newfoundland and Labrador, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2021,0,0
835,"Newfoundland and Labrador, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2022,0,0
836,"Newfoundland and Labrador, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2018,2,0.8
837,"Newfoundland and Labrador, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2019,2,0.5
838,"Newfoundland and Labrador, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2020,2,0.8
839,"Newfoundland and Labrador, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2021,7,2.6
840,"Newfoundland and Labrador, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2022,3,0.7
841,"Newfoundland and Labrador, place of residence",Females,"Total, all causes of death  [A00-Y89]",2018,"2,549",737.3
842,"Newfoundland and Labrador, place of residence",Females,"Total, all causes of death  [A00-Y89]",2019,"2,467",695.9
843,"Newfoundland and Labrador, place of residence",Females,"Total, all causes of death  [A00-Y89]",2020,"2,576",709.8
844,"Newfoundland and Labrador, place of residence",Females,"Total, all causes of death  [A00-Y89]",2021,"2,810",750.2
845,"Newfoundland and Labrador, place of residence",Females,"Total, all causes of death  [A00-Y89]",2022,"3,026",795.6
846,"Newfoundland and Labrador, place of residence",Females,Salmonella infections  [A01-A02],2018,0,0
847,"Newfoundland and Labrador, place of residence",Females,Salmonella infections  [A01-A02],2019,0,0
848,"Newfoundland and Labrador, place of residence",Females,Salmonella infections  [A01-A02],2020,0,0
849,"Newfoundland and Labrador, place of residence",Females,Salmonella infections  [A01-A02],2021,1,0.3
850,"Newfoundland and Labrador, place of residence",Females,Salmonella infections  [A01-A02],2022,0,0
851,"Newfoundland and Labrador, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2018,0,0
852,"Newfoundland and Labrador, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2019,0,0
853,"Newfoundland and Labrador, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2020,0,0
854,"Newfoundland and Labrador, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2021,0,0
855,"Newfoundland and Labrador, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2022,0,0
856,"Newfoundland and Labrador, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2018,7,1.9
857,"Newfoundland and Labrador, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2019,4,1.1
858,"Newfoundland and Labrador, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2020,3,0.9
859,"Newfoundland and Labrador, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2021,6,1.7
860,"Newfoundland and Labrador, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2022,4,0.9
861,"Newfoundland and Labrador, place of residence",Females,Tuberculosis  [A16-A19],2018,1,0.3
862,"Newfoundland and Labrador, place of residence",Females,Tuberculosis  [A16-A19],2019,1,0.3
863,"Newfoundland and Labrador, place of residence",Females,Tuberculosis  [A16-A19],2020,0,0
864,"Newfoundland and Labrador, place of residence",Females,Tuberculosis  [A16-A19],2021,1,0.3
865,"Newfoundland and Labrador, place of residence",Females,Tuberculosis  [A16-A19],2022,1,0.3
866,"Newfoundland and Labrador, place of residence",Females,Whooping cough  [A37],2018,0,0
867,"Newfoundland and Labrador, place of residence",Females,Whooping cough  [A37],2019,0,0
868,"Newfoundland and Labrador, place of residence",Females,Whooping cough  [A37],2020,0,0
869,"Newfoundland and Labrador, place of residence",Females,Whooping cough  [A37],2021,0,0
870,"Newfoundland and Labrador, place of residence",Females,Whooping cough  [A37],2022,0,0
871,"Newfoundland and Labrador, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2018,0,0
872,"Newfoundland and Labrador, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2019,0,0
873,"Newfoundland and Labrador, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2020,0,0
874,"Newfoundland and Labrador, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2021,0,0
875,"Newfoundland and Labrador, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2022,0,0
876,"Newfoundland and Labrador, place of residence",Females,Meningococcal infection  [A39],2018,1,0.2
877,"Newfoundland and Labrador, place of residence",Females,Meningococcal infection  [A39],2019,0,0
878,"Newfoundland and Labrador, place of residence",Females,Meningococcal infection  [A39],2020,0,0
879,"Newfoundland and Labrador, place of residence",Females,Meningococcal infection  [A39],2021,0,0
880,"Newfoundland and Labrador, place of residence",Females,Meningococcal infection  [A39],2022,1,0.6
881,"Newfoundland and Labrador, place of residence",Females,Sepsis  [A40-A41],2018,16,4.8
882,"Newfoundland and Labrador, place of residence",Females,Sepsis  [A40-A41],2019,21,6.1
883,"Newfoundland and Labrador, place of residence",Females,Sepsis  [A40-A41],2020,27,7.4
884,"Newfoundland and Labrador, place of residence",Females,Sepsis  [A40-A41],2021,17,4.4
885,"Newfoundland and Labrador, place of residence",Females,Sepsis  [A40-A41],2022,35,9.5
886,"Newfoundland and Labrador, place of residence",Females,Syphilis  [A50-A53],2018,0,0
887,"Newfoundland and Labrador, place of residence",Females,Syphilis  [A50-A53],2019,0,0
888,"Newfoundland and Labrador, place of residence",Females,Syphilis  [A50-A53],2020,0,0
889,"Newfoundland and Labrador, place of residence",Females,Syphilis  [A50-A53],2021,0,0
890,"Newfoundland and Labrador, place of residence",Females,Syphilis  [A50-A53],2022,0,0
891,"Newfoundland and Labrador, place of residence",Females,Acute poliomyelitis  [A80],2018,0,0
892,"Newfoundland and Labrador, place of residence",Females,Acute poliomyelitis  [A80],2019,0,0
893,"Newfoundland and Labrador, place of residence",Females,Acute poliomyelitis  [A80],2020,0,0
894,"Newfoundland and Labrador, place of residence",Females,Acute poliomyelitis  [A80],2021,0,0
895,"Newfoundland and Labrador, place of residence",Females,Acute poliomyelitis  [A80],2022,0,0
896,"Newfoundland and Labrador, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2018,0,0
897,"Newfoundland and Labrador, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2019,0,0
898,"Newfoundland and Labrador, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2020,0,0
899,"Newfoundland and Labrador, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2021,0,0
900,"Newfoundland and Labrador, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2022,0,0
901,"Newfoundland and Labrador, place of residence",Females,Measles  [B05],2018,0,0
902,"Newfoundland and Labrador, place of residence",Females,Measles  [B05],2019,0,0
903,"Newfoundland and Labrador, place of residence",Females,Measles  [B05],2020,0,0
904,"Newfoundland and Labrador, place of residence",Females,Measles  [B05],2021,0,0
905,"Newfoundland and Labrador, place of residence",Females,Measles  [B05],2022,0,0
906,"Newfoundland and Labrador, place of residence",Females,Viral hepatitis  [B15-B19],2018,0,0
907,"Newfoundland and Labrador, place of residence",Females,Viral hepatitis  [B15-B19],2019,1,0.2
908,"Newfoundland and Labrador, place of residence",Females,Viral hepatitis  [B15-B19],2020,0,0
909,"Newfoundland and Labrador, place of residence",Females,Viral hepatitis  [B15-B19],2021,0,0
910,"Newfoundland and Labrador, place of residence",Females,Viral hepatitis  [B15-B19],2022,1,0.3
911,"Newfoundland and Labrador, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2018,0,0
912,"Newfoundland and Labrador, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2019,0,0
913,"Newfoundland and Labrador, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2020,0,0
914,"Newfoundland and Labrador, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2021,0,0
915,"Newfoundland and Labrador, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2022,0,0
916,"Newfoundland and Labrador, place of residence",Females,Malaria  [B50-B54],2018,0,0
917,"Newfoundland and Labrador, place of residence",Females,Malaria  [B50-B54],2019,0,0
918,"Newfoundland and Labrador, place of residence",Females,Malaria  [B50-B54],2020,0,0
919,"Newfoundland and Labrador, place of residence",Females,Malaria  [B50-B54],2021,0,0
920,"Newfoundland and Labrador, place of residence",Females,Malaria  [B50-B54],2022,0,0
921,"Newfoundland and Labrador, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2018,4,1
922,"Newfoundland and Labrador, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2019,6,1.5
923,"Newfoundland and Labrador, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2020,5,1.5
924,"Newfoundland and Labrador, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2021,4,1
925,"Newfoundland and Labrador, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2022,9,2.4
926,"Newfoundland and Labrador, place of residence",Females,Malignant neoplasms  [C00-C97],2018,689,195.6
927,"Newfoundland and Labrador, place of residence",Females,Malignant neoplasms  [C00-C97],2019,651,181.1
928,"Newfoundland and Labrador, place of residence",Females,Malignant neoplasms  [C00-C97],2020,701,187.3
929,"Newfoundland and Labrador, place of residence",Females,Malignant neoplasms  [C00-C97],2021,778,202.5
930,"Newfoundland and Labrador, place of residence",Females,Malignant neoplasms  [C00-C97],2022,678,171.7
931,"Newfoundland and Labrador, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2018,12,3.5
932,"Newfoundland and Labrador, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2019,16,4.5
933,"Newfoundland and Labrador, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2020,16,4.6
934,"Newfoundland and Labrador, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2021,16,4.8
935,"Newfoundland and Labrador, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2022,15,3.7
936,"Newfoundland and Labrador, place of residence",Females,Anaemias  [D50-D64],2018,9,2.6
937,"Newfoundland and Labrador, place of residence",Females,Anaemias  [D50-D64],2019,7,2
938,"Newfoundland and Labrador, place of residence",Females,Anaemias  [D50-D64],2020,8,2.5
939,"Newfoundland and Labrador, place of residence",Females,Anaemias  [D50-D64],2021,7,2.2
940,"Newfoundland and Labrador, place of residence",Females,Anaemias  [D50-D64],2022,6,1.4
941,"Newfoundland and Labrador, place of residence",Females,Diabetes mellitus  [E10-E14],2018,118,34.6
942,"Newfoundland and Labrador, place of residence",Females,Diabetes mellitus  [E10-E14],2019,93,26.4
943,"Newfoundland and Labrador, place of residence",Females,Diabetes mellitus  [E10-E14],2020,128,35.1
944,"Newfoundland and Labrador, place of residence",Females,Diabetes mellitus  [E10-E14],2021,126,33.4
945,"Newfoundland and Labrador, place of residence",Females,Diabetes mellitus  [E10-E14],2022,97,25.9
946,"Newfoundland and Labrador, place of residence",Females,Nutritional deficiencies  [E40-E64],2018,5,1.5
947,"Newfoundland and Labrador, place of residence",Females,Nutritional deficiencies  [E40-E64],2019,2,0.6
948,"Newfoundland and Labrador, place of residence",Females,Nutritional deficiencies  [E40-E64],2020,2,0.5
949,"Newfoundland and Labrador, place of residence",Females,Nutritional deficiencies  [E40-E64],2021,3,0.8
950,"Newfoundland and Labrador, place of residence",Females,Nutritional deficiencies  [E40-E64],2022,1,0.2
951,"Newfoundland and Labrador, place of residence",Females,"Dementia  [F010-F019, F03]",2018,211,61.2
952,"Newfoundland and Labrador, place of residence",Females,"Dementia  [F010-F019, F03]",2019,270,75.4
953,"Newfoundland and Labrador, place of residence",Females,"Dementia  [F010-F019, F03]",2020,242,66.1
954,"Newfoundland and Labrador, place of residence",Females,"Dementia  [F010-F019, F03]",2021,285,75.6
955,"Newfoundland and Labrador, place of residence",Females,"Dementia  [F010-F019, F03]",2022,261,69
956,"Newfoundland and Labrador, place of residence",Females,"Meningitis  [G00, G03]",2018,0,0
957,"Newfoundland and Labrador, place of residence",Females,"Meningitis  [G00, G03]",2019,0,0
958,"Newfoundland and Labrador, place of residence",Females,"Meningitis  [G00, G03]",2020,1,0.3
959,"Newfoundland and Labrador, place of residence",Females,"Meningitis  [G00, G03]",2021,0,0
960,"Newfoundland and Labrador, place of residence",Females,"Meningitis  [G00, G03]",2022,0,0
961,"Newfoundland and Labrador, place of residence",Females,Parkinson's disease  [G20-G21],2018,29,8.6
962,"Newfoundland and Labrador, place of residence",Females,Parkinson's disease  [G20-G21],2019,24,7
963,"Newfoundland and Labrador, place of residence",Females,Parkinson's disease  [G20-G21],2020,25,6.4
964,"Newfoundland and Labrador, place of residence",Females,Parkinson's disease  [G20-G21],2021,27,6.7
965,"Newfoundland and Labrador, place of residence",Females,Parkinson's disease  [G20-G21],2022,25,6
966,"Newfoundland and Labrador, place of residence",Females,Alzheimer's disease  [G30],2018,40,11.9
967,"Newfoundland and Labrador, place of residence",Females,Alzheimer's disease  [G30],2019,30,8.5
968,"Newfoundland and Labrador, place of residence",Females,Alzheimer's disease  [G30],2020,26,7.1
969,"Newfoundland and Labrador, place of residence",Females,Alzheimer's disease  [G30],2021,37,9.8
970,"Newfoundland and Labrador, place of residence",Females,Alzheimer's disease  [G30],2022,36,9.3
971,"Newfoundland and Labrador, place of residence",Females,Major cardiovascular diseases  [I00-I78],2018,686,195.4
972,"Newfoundland and Labrador, place of residence",Females,Major cardiovascular diseases  [I00-I78],2019,619,173.3
973,"Newfoundland and Labrador, place of residence",Females,Major cardiovascular diseases  [I00-I78],2020,673,184.2
974,"Newfoundland and Labrador, place of residence",Females,Major cardiovascular diseases  [I00-I78],2021,699,183.9
975,"Newfoundland and Labrador, place of residence",Females,Major cardiovascular diseases  [I00-I78],2022,576,151.1
976,"Newfoundland and Labrador, place of residence",Females,Other disorders of circulatory system  [I80-I99],2018,5,1.5
977,"Newfoundland and Labrador, place of residence",Females,Other disorders of circulatory system  [I80-I99],2019,3,0.8
978,"Newfoundland and Labrador, place of residence",Females,Other disorders of circulatory system  [I80-I99],2020,8,2.4
979,"Newfoundland and Labrador, place of residence",Females,Other disorders of circulatory system  [I80-I99],2021,5,1.8
980,"Newfoundland and Labrador, place of residence",Females,Other disorders of circulatory system  [I80-I99],2022,11,3.2
981,"Newfoundland and Labrador, place of residence",Females,Influenza and pneumonia  [J09-J18],2018,82,23.8
982,"Newfoundland and Labrador, place of residence",Females,Influenza and pneumonia  [J09-J18],2019,64,18
983,"Newfoundland and Labrador, place of residence",Females,Influenza and pneumonia  [J09-J18],2020,51,14.1
984,"Newfoundland and Labrador, place of residence",Females,Influenza and pneumonia  [J09-J18],2021,35,9.5
985,"Newfoundland and Labrador, place of residence",Females,Influenza and pneumonia  [J09-J18],2022,38,10
986,"Newfoundland and Labrador, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2018,7,2.1
987,"Newfoundland and Labrador, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2019,3,0.9
988,"Newfoundland and Labrador, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2020,3,0.9
989,"Newfoundland and Labrador, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2021,0,0
990,"Newfoundland and Labrador, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2022,1,0.3
991,"Newfoundland and Labrador, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2018,115,33
992,"Newfoundland and Labrador, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2019,120,32.7
993,"Newfoundland and Labrador, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2020,107,28.9
994,"Newfoundland and Labrador, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2021,107,27.9
995,"Newfoundland and Labrador, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2022,95,23.5
996,"Newfoundland and Labrador, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2018,0,0
997,"Newfoundland and Labrador, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2019,1,0.3
998,"Newfoundland and Labrador, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2020,0,0
999,"Newfoundland and Labrador, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2021,0,0
1000,"Newfoundland and Labrador, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2022,0,0
1001,"Newfoundland and Labrador, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2018,10,2.9
1002,"Newfoundland and Labrador, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2019,10,2.7
1003,"Newfoundland and Labrador, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2020,9,2.7
1004,"Newfoundland and Labrador, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2021,8,2.2
1005,"Newfoundland and Labrador, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2022,4,1.1
1006,"Newfoundland and Labrador, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2018,23,6.4
1007,"Newfoundland and Labrador, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2019,23,6.3
1008,"Newfoundland and Labrador, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2020,30,7.9
1009,"Newfoundland and Labrador, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2021,28,7.1
1010,"Newfoundland and Labrador, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2022,39,10
1011,"Newfoundland and Labrador, place of residence",Females,Peptic ulcer  [K25-K28],2018,1,0.3
1012,"Newfoundland and Labrador, place of residence",Females,Peptic ulcer  [K25-K28],2019,3,0.8
1013,"Newfoundland and Labrador, place of residence",Females,Peptic ulcer  [K25-K28],2020,4,1.2
1014,"Newfoundland and Labrador, place of residence",Females,Peptic ulcer  [K25-K28],2021,1,0.2
1015,"Newfoundland and Labrador, place of residence",Females,Peptic ulcer  [K25-K28],2022,0,0
1016,"Newfoundland and Labrador, place of residence",Females,Diseases of appendix  [K35-K38],2018,0,0
1017,"Newfoundland and Labrador, place of residence",Females,Diseases of appendix  [K35-K38],2019,0,0
1018,"Newfoundland and Labrador, place of residence",Females,Diseases of appendix  [K35-K38],2020,0,0
1019,"Newfoundland and Labrador, place of residence",Females,Diseases of appendix  [K35-K38],2021,0,0
1020,"Newfoundland and Labrador, place of residence",Females,Diseases of appendix  [K35-K38],2022,0,0
1021,"Newfoundland and Labrador, place of residence",Females,Hernia  [K40-K46],2018,1,0.3
1022,"Newfoundland and Labrador, place of residence",Females,Hernia  [K40-K46],2019,3,0.8
1023,"Newfoundland and Labrador, place of residence",Females,Hernia  [K40-K46],2020,2,0.4
1024,"Newfoundland and Labrador, place of residence",Females,Hernia  [K40-K46],2021,9,2.2
1025,"Newfoundland and Labrador, place of residence",Females,Hernia  [K40-K46],2022,1,0.3
1026,"Newfoundland and Labrador, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2018,20,5.8
1027,"Newfoundland and Labrador, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2019,28,7.2
1028,"Newfoundland and Labrador, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2020,29,8.6
1029,"Newfoundland and Labrador, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2021,35,9.6
1030,"Newfoundland and Labrador, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2022,33,9.6
1031,"Newfoundland and Labrador, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2018,3,0.8
1032,"Newfoundland and Labrador, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2019,5,1.2
1033,"Newfoundland and Labrador, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2020,4,1.1
1034,"Newfoundland and Labrador, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2021,11,2.8
1035,"Newfoundland and Labrador, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2022,9,2.3
1036,"Newfoundland and Labrador, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2018,55,15.8
1037,"Newfoundland and Labrador, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2019,65,18.3
1038,"Newfoundland and Labrador, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2020,61,16.2
1039,"Newfoundland and Labrador, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2021,78,20.3
1040,"Newfoundland and Labrador, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2022,55,14.6
1041,"Newfoundland and Labrador, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2018,2,0.6
1042,"Newfoundland and Labrador, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2019,0,0
1043,"Newfoundland and Labrador, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2020,1,0.3
1044,"Newfoundland and Labrador, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2021,0,0
1045,"Newfoundland and Labrador, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2022,3,0.7
1046,"Newfoundland and Labrador, place of residence",Females,Hyperplasia of prostate  [N40],2018,...,...
1047,"Newfoundland and Labrador, place of residence",Females,Hyperplasia of prostate  [N40],2019,...,...
1048,"Newfoundland and Labrador, place of residence",Females,Hyperplasia of prostate  [N40],2020,...,...
1049,"Newfoundland and Labrador, place of residence",Females,Hyperplasia of prostate  [N40],2021,...,...
1050,"Newfoundland and Labrador, place of residence",Females,Hyperplasia of prostate  [N40],2022,...,...
1051,"Newfoundland and Labrador, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2018,1,0.3
1052,"Newfoundland and Labrador, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2019,1,0.3
1053,"Newfoundland and Labrador, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2020,0,0
1054,"Newfoundland and Labrador, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2021,0,0
1055,"Newfoundland and Labrador, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2022,1,0.3
1056,"Newfoundland and Labrador, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2018,0,0
1057,"Newfoundland and Labrador, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2019,0,0
1058,"Newfoundland and Labrador, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2020,1,0.4
1059,"Newfoundland and Labrador, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2021,0,0
1060,"Newfoundland and Labrador, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2022,0,0
1061,"Newfoundland and Labrador, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2018,3,1.7
1062,"Newfoundland and Labrador, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2019,7,4.1
1063,"Newfoundland and Labrador, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2020,6,3.7
1064,"Newfoundland and Labrador, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2021,5,3.1
1065,"Newfoundland and Labrador, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2022,2,1.2
1066,"Newfoundland and Labrador, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2018,6,2.4
1067,"Newfoundland and Labrador, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2019,9,3.2
1068,"Newfoundland and Labrador, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2020,10,3.8
1069,"Newfoundland and Labrador, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2021,17,5.1
1070,"Newfoundland and Labrador, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2022,8,3.1
1071,"Newfoundland and Labrador, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2018,80,24
1072,"Newfoundland and Labrador, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2019,71,20.4
1073,"Newfoundland and Labrador, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2020,69,20.1
1074,"Newfoundland and Labrador, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2021,97,28.6
1075,"Newfoundland and Labrador, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2022,499,135.5
1076,"Newfoundland and Labrador, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2018,..,..
1077,"Newfoundland and Labrador, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2019,..,..
1078,"Newfoundland and Labrador, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2020,2,0.5
1079,"Newfoundland and Labrador, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2021,3,0.8
1080,"Newfoundland and Labrador, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2022,136,34.5
1081,"Newfoundland and Labrador, place of residence",Females,All other diseases (residual) 26,2018,206,59.8
1082,"Newfoundland and Labrador, place of residence",Females,All other diseases (residual) 26,2019,215,59.8
1083,"Newfoundland and Labrador, place of residence",Females,All other diseases (residual) 26,2020,229,63.3
1084,"Newfoundland and Labrador, place of residence",Females,All other diseases (residual) 26,2021,254,68.1
1085,"Newfoundland and Labrador, place of residence",Females,All other diseases (residual) 26,2022,253,65.9
1086,"Newfoundland and Labrador, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2018,80,25.1
1087,"Newfoundland and Labrador, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2019,66,20.6
1088,"Newfoundland and Labrador, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2020,72,22
1089,"Newfoundland and Labrador, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2021,83,23.9
1090,"Newfoundland and Labrador, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2022,76,21.4
1091,"Newfoundland and Labrador, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2018,12,4.3
1092,"Newfoundland and Labrador, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2019,16,6.3
1093,"Newfoundland and Labrador, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2020,12,4.9
1094,"Newfoundland and Labrador, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2021,17,6.6
1095,"Newfoundland and Labrador, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2022,11,4.2
1096,"Newfoundland and Labrador, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2018,0,0
1097,"Newfoundland and Labrador, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2019,2,0.9
1098,"Newfoundland and Labrador, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2020,0,0
1099,"Newfoundland and Labrador, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2021,3,1.3
1100,"Newfoundland and Labrador, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2022,1,0.5
1101,"Newfoundland and Labrador, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2018,0,0
1102,"Newfoundland and Labrador, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2019,0,0
1103,"Newfoundland and Labrador, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2020,0,0
1104,"Newfoundland and Labrador, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2021,0,0
1105,"Newfoundland and Labrador, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2022,0,0
1106,"Newfoundland and Labrador, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2018,5,2.1
1107,"Newfoundland and Labrador, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2019,4,1.7
1108,"Newfoundland and Labrador, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2020,6,2
1109,"Newfoundland and Labrador, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2021,1,0.2
1110,"Newfoundland and Labrador, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2022,2,0.4
1111,"Newfoundland and Labrador, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2018,0,0
1112,"Newfoundland and Labrador, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2019,0,0
1113,"Newfoundland and Labrador, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2020,0,0
1114,"Newfoundland and Labrador, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2021,0,0
1115,"Newfoundland and Labrador, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2022,0,0
1116,"Newfoundland and Labrador, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2018,4,1.1
1117,"Newfoundland and Labrador, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2019,3,0.8
1118,"Newfoundland and Labrador, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2020,3,0.8
1119,"Newfoundland and Labrador, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2021,6,1.5
1120,"Newfoundland and Labrador, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2022,2,0.5
1121,"British Columbia, place of residence",Males,"Total, all causes of death  [A00-Y89]",2018,"20,493",787
1122,"British Columbia, place of residence",Males,"Total, all causes of death  [A00-Y89]",2019,"20,300",752.1
1123,"British Columbia, place of residence",Males,"Total, all causes of death  [A00-Y89]",2020,"22,585",812.7
1124,"British Columbia, place of residence",Males,"Total, all causes of death  [A00-Y89]",2021,"24,337",853.5
1125,"British Columbia, place of residence",Males,"Total, all causes of death  [A00-Y89]",2022,"25,093",858.8
1126,"British Columbia, place of residence",Males,Salmonella infections  [A01-A02],2018,0,0
1127,"British Columbia, place of residence",Males,Salmonella infections  [A01-A02],2019,1,0
1128,"British Columbia, place of residence",Males,Salmonella infections  [A01-A02],2020,2,0.1
1129,"British Columbia, place of residence",Males,Salmonella infections  [A01-A02],2021,0,0
1130,"British Columbia, place of residence",Males,Salmonella infections  [A01-A02],2022,0,0
1131,"British Columbia, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2018,0,0
1132,"British Columbia, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2019,0,0
1133,"British Columbia, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2020,0,0
1134,"British Columbia, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2021,0,0
1135,"British Columbia, place of residence",Males,"Shigellosis and amoebiasis  [A03, A06]",2022,0,0
1136,"British Columbia, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2018,46,1.8
1137,"British Columbia, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2019,30,1.1
1138,"British Columbia, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2020,28,1
1139,"British Columbia, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2021,22,0.8
1140,"British Columbia, place of residence",Males,"Certain other intestinal infections  [A04, A07-A09]",2022,31,1
1141,"British Columbia, place of residence",Males,Tuberculosis  [A16-A19],2018,9,0.3
1142,"British Columbia, place of residence",Males,Tuberculosis  [A16-A19],2019,6,0.2
1143,"British Columbia, place of residence",Males,Tuberculosis  [A16-A19],2020,4,0.2
1144,"British Columbia, place of residence",Males,Tuberculosis  [A16-A19],2021,10,0.4
1145,"British Columbia, place of residence",Males,Tuberculosis  [A16-A19],2022,9,0.3
1146,"British Columbia, place of residence",Males,Whooping cough  [A37],2018,0,0
1147,"British Columbia, place of residence",Males,Whooping cough  [A37],2019,0,0
1148,"British Columbia, place of residence",Males,Whooping cough  [A37],2020,0,0
1149,"British Columbia, place of residence",Males,Whooping cough  [A37],2021,0,0
1150,"British Columbia, place of residence",Males,Whooping cough  [A37],2022,0,0
1151,"British Columbia, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2018,0,0
1152,"British Columbia, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2019,0,0
1153,"British Columbia, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2020,0,0
1154,"British Columbia, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2021,0,0
1155,"British Columbia, place of residence",Males,"Scarlet fever and erysipelas  [A38, A46]",2022,0,0
1156,"British Columbia, place of residence",Males,Meningococcal infection  [A39],2018,0,0
1157,"British Columbia, place of residence",Males,Meningococcal infection  [A39],2019,1,0
1158,"British Columbia, place of residence",Males,Meningococcal infection  [A39],2020,1,0
1159,"British Columbia, place of residence",Males,Meningococcal infection  [A39],2021,0,0
1160,"British Columbia, place of residence",Males,Meningococcal infection  [A39],2022,1,0
1161,"British Columbia, place of residence",Males,Sepsis  [A40-A41],2018,59,2.3
1162,"British Columbia, place of residence",Males,Sepsis  [A40-A41],2019,79,3
1163,"British Columbia, place of residence",Males,Sepsis  [A40-A41],2020,85,3
1164,"British Columbia, place of residence",Males,Sepsis  [A40-A41],2021,97,3.4
1165,"British Columbia, place of residence",Males,Sepsis  [A40-A41],2022,105,3.6
1166,"British Columbia, place of residence",Males,Syphilis  [A50-A53],2018,1,0
1167,"British Columbia, place of residence",Males,Syphilis  [A50-A53],2019,1,0
1168,"British Columbia, place of residence",Males,Syphilis  [A50-A53],2020,1,0
1169,"British Columbia, place of residence",Males,Syphilis  [A50-A53],2021,0,0
1170,"British Columbia, place of residence",Males,Syphilis  [A50-A53],2022,2,0.1
1171,"British Columbia, place of residence",Males,Acute poliomyelitis  [A80],2018,0,0
1172,"British Columbia, place of residence",Males,Acute poliomyelitis  [A80],2019,0,0
1173,"British Columbia, place of residence",Males,Acute poliomyelitis  [A80],2020,0,0
1174,"British Columbia, place of residence",Males,Acute poliomyelitis  [A80],2021,0,0
1175,"British Columbia, place of residence",Males,Acute poliomyelitis  [A80],2022,0,0
1176,"British Columbia, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2018,0,0
1177,"British Columbia, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2019,0,0
1178,"British Columbia, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2020,0,0
1179,"British Columbia, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2021,0,0
1180,"British Columbia, place of residence",Males,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2022,0,0
1181,"British Columbia, place of residence",Males,Measles  [B05],2018,0,0
1182,"British Columbia, place of residence",Males,Measles  [B05],2019,0,0
1183,"British Columbia, place of residence",Males,Measles  [B05],2020,0,0
1184,"British Columbia, place of residence",Males,Measles  [B05],2021,0,0
1185,"British Columbia, place of residence",Males,Measles  [B05],2022,0,0
1186,"British Columbia, place of residence",Males,Viral hepatitis  [B15-B19],2018,73,2.7
1187,"British Columbia, place of residence",Males,Viral hepatitis  [B15-B19],2019,39,1.3
1188,"British Columbia, place of residence",Males,Viral hepatitis  [B15-B19],2020,40,1.4
1189,"British Columbia, place of residence",Males,Viral hepatitis  [B15-B19],2021,40,1.4
1190,"British Columbia, place of residence",Males,Viral hepatitis  [B15-B19],2022,27,0.9
1191,"British Columbia, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2018,21,0.8
1192,"British Columbia, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2019,6,0.2
1193,"British Columbia, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2020,4,0.2
1194,"British Columbia, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2021,15,0.6
1195,"British Columbia, place of residence",Males,Human immunodeficiency virus [HIV] disease  [B20-B24],2022,10,0.4
1196,"British Columbia, place of residence",Males,Malaria  [B50-B54],2018,0,0
1197,"British Columbia, place of residence",Males,Malaria  [B50-B54],2019,0,0
1198,"British Columbia, place of residence",Males,Malaria  [B50-B54],2020,0,0
1199,"British Columbia, place of residence",Males,Malaria  [B50-B54],2021,0,0
1200,"British Columbia, place of residence",Males,Malaria  [B50-B54],2022,0,0
1201,"British Columbia, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2018,54,2.1
1202,"British Columbia, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2019,53,2
1203,"British Columbia, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2020,46,1.6
1204,"British Columbia, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2021,81,2.8
1205,"British Columbia, place of residence",Males,Other and unspecified infectious and parasitic diseases and their sequelae 25,2022,79,2.6
1206,"British Columbia, place of residence",Males,Malignant neoplasms  [C00-C97],2018,"5,633",207.3
1207,"British Columbia, place of residence",Males,Malignant neoplasms  [C00-C97],2019,"5,731",204.3
1208,"British Columbia, place of residence",Males,Malignant neoplasms  [C00-C97],2020,"5,890",203.2
1209,"British Columbia, place of residence",Males,Malignant neoplasms  [C00-C97],2021,"5,902",197.1
1210,"British Columbia, place of residence",Males,Malignant neoplasms  [C00-C97],2022,"5,914",192.3
1211,"British Columbia, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2018,108,4.2
1212,"British Columbia, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2019,151,5.5
1213,"British Columbia, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2020,139,5
1214,"British Columbia, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2021,141,4.8
1215,"British Columbia, place of residence",Males,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2022,148,4.9
1216,"British Columbia, place of residence",Males,Anaemias  [D50-D64],2018,23,0.9
1217,"British Columbia, place of residence",Males,Anaemias  [D50-D64],2019,26,1
1218,"British Columbia, place of residence",Males,Anaemias  [D50-D64],2020,39,1.4
1219,"British Columbia, place of residence",Males,Anaemias  [D50-D64],2021,28,1
1220,"British Columbia, place of residence",Males,Anaemias  [D50-D64],2022,32,1.1
1221,"British Columbia, place of residence",Males,Diabetes mellitus  [E10-E14],2018,625,23.4
1222,"British Columbia, place of residence",Males,Diabetes mellitus  [E10-E14],2019,669,24.2
1223,"British Columbia, place of residence",Males,Diabetes mellitus  [E10-E14],2020,743,26.2
1224,"British Columbia, place of residence",Males,Diabetes mellitus  [E10-E14],2021,723,24.9
1225,"British Columbia, place of residence",Males,Diabetes mellitus  [E10-E14],2022,795,26.9
1226,"British Columbia, place of residence",Males,Nutritional deficiencies  [E40-E64],2018,6,0.2
1227,"British Columbia, place of residence",Males,Nutritional deficiencies  [E40-E64],2019,15,0.6
1228,"British Columbia, place of residence",Males,Nutritional deficiencies  [E40-E64],2020,15,0.5
1229,"British Columbia, place of residence",Males,Nutritional deficiencies  [E40-E64],2021,21,0.7
1230,"British Columbia, place of residence",Males,Nutritional deficiencies  [E40-E64],2022,18,0.6
1231,"British Columbia, place of residence",Males,"Dementia  [F010-F019, F03]",2018,"1,167",47.9
1232,"British Columbia, place of residence",Males,"Dementia  [F010-F019, F03]",2019,"1,244",48.9
1233,"British Columbia, place of residence",Males,"Dementia  [F010-F019, F03]",2020,"1,290",48.3
1234,"British Columbia, place of residence",Males,"Dementia  [F010-F019, F03]",2021,"1,308",47.7
1235,"British Columbia, place of residence",Males,"Dementia  [F010-F019, F03]",2022,"1,430",50.7
1236,"British Columbia, place of residence",Males,"Meningitis  [G00, G03]",2018,11,0.4
1237,"British Columbia, place of residence",Males,"Meningitis  [G00, G03]",2019,6,0.2
1238,"British Columbia, place of residence",Males,"Meningitis  [G00, G03]",2020,6,0.2
1239,"British Columbia, place of residence",Males,"Meningitis  [G00, G03]",2021,5,0.2
1240,"British Columbia, place of residence",Males,"Meningitis  [G00, G03]",2022,10,0.4
1241,"British Columbia, place of residence",Males,Parkinson's disease  [G20-G21],2018,277,10.7
1242,"British Columbia, place of residence",Males,Parkinson's disease  [G20-G21],2019,317,11.9
1243,"British Columbia, place of residence",Males,Parkinson's disease  [G20-G21],2020,317,11.2
1244,"British Columbia, place of residence",Males,Parkinson's disease  [G20-G21],2021,349,12
1245,"British Columbia, place of residence",Males,Parkinson's disease  [G20-G21],2022,365,12.3
1246,"British Columbia, place of residence",Males,Alzheimer's disease  [G30],2018,342,13.7
1247,"British Columbia, place of residence",Males,Alzheimer's disease  [G30],2019,365,14.1
1248,"British Columbia, place of residence",Males,Alzheimer's disease  [G30],2020,408,15.1
1249,"British Columbia, place of residence",Males,Alzheimer's disease  [G30],2021,398,14.1
1250,"British Columbia, place of residence",Males,Alzheimer's disease  [G30],2022,397,13.4
1251,"British Columbia, place of residence",Males,Major cardiovascular diseases  [I00-I78],2018,"5,353",206.3
1252,"British Columbia, place of residence",Males,Major cardiovascular diseases  [I00-I78],2019,"5,156",192
1253,"British Columbia, place of residence",Males,Major cardiovascular diseases  [I00-I78],2020,"5,418",194.2
1254,"British Columbia, place of residence",Males,Major cardiovascular diseases  [I00-I78],2021,"5,571",194.4
1255,"British Columbia, place of residence",Males,Major cardiovascular diseases  [I00-I78],2022,"5,915",201
1256,"British Columbia, place of residence",Males,Other disorders of circulatory system  [I80-I99],2018,25,1
1257,"British Columbia, place of residence",Males,Other disorders of circulatory system  [I80-I99],2019,32,1.2
1258,"British Columbia, place of residence",Males,Other disorders of circulatory system  [I80-I99],2020,22,0.8
1259,"British Columbia, place of residence",Males,Other disorders of circulatory system  [I80-I99],2021,22,0.8
1260,"British Columbia, place of residence",Males,Other disorders of circulatory system  [I80-I99],2022,26,0.9
1261,"British Columbia, place of residence",Males,Influenza and pneumonia  [J09-J18],2018,442,17.5
1262,"British Columbia, place of residence",Males,Influenza and pneumonia  [J09-J18],2019,380,14.5
1263,"British Columbia, place of residence",Males,Influenza and pneumonia  [J09-J18],2020,362,13.2
1264,"British Columbia, place of residence",Males,Influenza and pneumonia  [J09-J18],2021,280,10
1265,"British Columbia, place of residence",Males,Influenza and pneumonia  [J09-J18],2022,388,13.3
1266,"British Columbia, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2018,2,0.1
1267,"British Columbia, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2019,5,0.2
1268,"British Columbia, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2020,5,0.2
1269,"British Columbia, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2021,0,0
1270,"British Columbia, place of residence",Males,Other acute lower respiratory infections  [J20-J22],2022,2,0.1
1271,"British Columbia, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2018,910,34.4
1272,"British Columbia, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2019,934,33.9
1273,"British Columbia, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2020,883,30.6
1274,"British Columbia, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2021,792,26.8
1275,"British Columbia, place of residence",Males,Chronic lower respiratory diseases  [J40-J47],2022,911,29.7
1276,"British Columbia, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2018,16,0.6
1277,"British Columbia, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2019,23,0.9
1278,"British Columbia, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2020,19,0.7
1279,"British Columbia, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2021,13,0.4
1280,"British Columbia, place of residence",Males,"Pneumoconioses and chemical effects  [J60-J66, J68]",2022,9,0.3
1281,"British Columbia, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2018,110,4.4
1282,"British Columbia, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2019,99,3.8
1283,"British Columbia, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2020,122,4.5
1284,"British Columbia, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2021,146,5.2
1285,"British Columbia, place of residence",Males,Pneumonitis due to solids and liquids  [J69],2022,163,5.6
1286,"British Columbia, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2018,252,9.7
1287,"British Columbia, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2019,275,10.1
1288,"British Columbia, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2020,243,8.5
1289,"British Columbia, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2021,262,8.9
1290,"British Columbia, place of residence",Males,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2022,292,9.6
1291,"British Columbia, place of residence",Males,Peptic ulcer  [K25-K28],2018,25,1
1292,"British Columbia, place of residence",Males,Peptic ulcer  [K25-K28],2019,43,1.6
1293,"British Columbia, place of residence",Males,Peptic ulcer  [K25-K28],2020,44,1.5
1294,"British Columbia, place of residence",Males,Peptic ulcer  [K25-K28],2021,62,2.2
1295,"British Columbia, place of residence",Males,Peptic ulcer  [K25-K28],2022,50,1.7
1296,"British Columbia, place of residence",Males,Diseases of appendix  [K35-K38],2018,3,0.1
1297,"British Columbia, place of residence",Males,Diseases of appendix  [K35-K38],2019,2,0.1
1298,"British Columbia, place of residence",Males,Diseases of appendix  [K35-K38],2020,3,0.1
1299,"British Columbia, place of residence",Males,Diseases of appendix  [K35-K38],2021,5,0.2
1300,"British Columbia, place of residence",Males,Diseases of appendix  [K35-K38],2022,5,0.2
1301,"British Columbia, place of residence",Males,Hernia  [K40-K46],2018,22,0.9
1302,"British Columbia, place of residence",Males,Hernia  [K40-K46],2019,20,0.7
1303,"British Columbia, place of residence",Males,Hernia  [K40-K46],2020,26,1
1304,"British Columbia, place of residence",Males,Hernia  [K40-K46],2021,25,0.9
1305,"British Columbia, place of residence",Males,Hernia  [K40-K46],2022,17,0.6
1306,"British Columbia, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2018,342,12.6
1307,"British Columbia, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2019,353,12.8
1308,"British Columbia, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2020,419,15.1
1309,"British Columbia, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2021,477,17
1310,"British Columbia, place of residence",Males,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2022,442,15.4
1311,"British Columbia, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2018,23,0.9
1312,"British Columbia, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2019,32,1.2
1313,"British Columbia, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2020,35,1.3
1314,"British Columbia, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2021,38,1.3
1315,"British Columbia, place of residence",Males,Cholelithiasis and other disorders of gallbladder  [K80-K82],2022,42,1.4
1316,"British Columbia, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2018,156,6.2
1317,"British Columbia, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2019,160,6.1
1318,"British Columbia, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2020,182,6.7
1319,"British Columbia, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2021,195,6.9
1320,"British Columbia, place of residence",Males,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2022,207,7.1
1321,"British Columbia, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2018,3,0.1
1322,"British Columbia, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2019,5,0.2
1323,"British Columbia, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2020,9,0.3
1324,"British Columbia, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2021,5,0.2
1325,"British Columbia, place of residence",Males,"Infections of kidney  [N10-N12, N13.6, N15.1]",2022,10,0.3
1326,"British Columbia, place of residence",Males,Hyperplasia of prostate  [N40],2018,18,0.7
1327,"British Columbia, place of residence",Males,Hyperplasia of prostate  [N40],2019,20,0.8
1328,"British Columbia, place of residence",Males,Hyperplasia of prostate  [N40],2020,23,0.8
1329,"British Columbia, place of residence",Males,Hyperplasia of prostate  [N40],2021,27,1
1330,"British Columbia, place of residence",Males,Hyperplasia of prostate  [N40],2022,29,1
1331,"British Columbia, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2018,...,...
1332,"British Columbia, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2019,...,...
1333,"British Columbia, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2020,...,...
1334,"British Columbia, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2021,...,...
1335,"British Columbia, place of residence",Males,Inflammatory diseases of female pelvic organs  [N70-N76],2022,...,...
1336,"British Columbia, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2018,...,...
1337,"British Columbia, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2019,...,...
1338,"British Columbia, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2020,...,...
1339,"British Columbia, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2021,...,...
1340,"British Columbia, place of residence",Males,"Pregnancy, childbirth and the puerperium  [O00-O99]",2022,...,...
1341,"British Columbia, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2018,68,3.3
1342,"British Columbia, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2019,59,2.9
1343,"British Columbia, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2020,57,2.8
1344,"British Columbia, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2021,45,2.2
1345,"British Columbia, place of residence",Males,Certain conditions originating in the perinatal period  [P00-P96],2022,43,2.1
1346,"British Columbia, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2018,56,2.4
1347,"British Columbia, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2019,49,1.9
1348,"British Columbia, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2020,52,2.1
1349,"British Columbia, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2021,57,2.2
1350,"British Columbia, place of residence",Males,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2022,82,3.2
1351,"British Columbia, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2018,556,22.3
1352,"British Columbia, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2019,740,28.6
1353,"British Columbia, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2020,"2,596",100.5
1354,"British Columbia, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2021,"2,506",93.3
1355,"British Columbia, place of residence",Males,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2022,"2,027",74.7
1356,"British Columbia, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2018,..,..
1357,"British Columbia, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2019,..,..
1358,"British Columbia, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2020,491,17.7
1359,"British Columbia, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2021,994,34.4
1360,"British Columbia, place of residence",Males,"COVID-19  [U07.1, U07.2, U10.9]",2022,"1,264",43.3
1361,"British Columbia, place of residence",Males,All other diseases (residual) 26,2018,"1,458",55.3
1362,"British Columbia, place of residence",Males,All other diseases (residual) 26,2019,"1,511",55.1
1363,"British Columbia, place of residence",Males,All other diseases (residual) 26,2020,"1,689",60
1364,"British Columbia, place of residence",Males,All other diseases (residual) 26,2021,"1,731",59.9
1365,"British Columbia, place of residence",Males,All other diseases (residual) 26,2022,"1,844",62.4
1366,"British Columbia, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2018,"1,757",70.7
1367,"British Columbia, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2019,"1,188",46.4
1368,"British Columbia, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2020,525,19.6
1369,"British Columbia, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2021,"1,669",63.2
1370,"British Columbia, place of residence",Males,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2022,"1,724",65
1371,"British Columbia, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2018,391,15.6
1372,"British Columbia, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2019,429,16.6
1373,"British Columbia, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2020,264,10.1
1374,"British Columbia, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2021,222,8.4
1375,"British Columbia, place of residence",Males,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2022,184,6.9
1376,"British Columbia, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2018,21,0.8
1377,"British Columbia, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2019,9,0.3
1378,"British Columbia, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2020,22,0.8
1379,"British Columbia, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2021,31,1.2
1380,"British Columbia, place of residence",Males,"Assault (homicide)  [X85-Y09, Y87.1]",2022,11,0.4
1381,"British Columbia, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2018,1,0
1382,"British Columbia, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2019,1,0
1383,"British Columbia, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2020,0,0
1384,"British Columbia, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2021,0,0
1385,"British Columbia, place of residence",Males,"Legal intervention  [Y35, Y89.0]",2022,0,0
1386,"British Columbia, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2018,20,0.8
1387,"British Columbia, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2019,23,0.9
1388,"British Columbia, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2020,10,0.4
1389,"British Columbia, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2021,12,0.5
1390,"British Columbia, place of residence",Males,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2022,9,0.3
1391,"British Columbia, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2018,0,0
1392,"British Columbia, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2019,0,0
1393,"British Columbia, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2020,0,0
1394,"British Columbia, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2021,1,0.1
1395,"British Columbia, place of residence",Males,"Operations of war and their sequelae  [Y36, Y89.1]",2022,0,0
1396,"British Columbia, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2018,8,0.3
1397,"British Columbia, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2019,12,0.4
1398,"British Columbia, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2020,6,0.2
1399,"British Columbia, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2021,9,0.3
1400,"British Columbia, place of residence",Males,"Complications of medical and surgical care  [Y40-Y84, Y88]",2022,23,0.7
1401,"British Columbia, place of residence",Females,"Total, all causes of death  [A00-Y89]",2018,"17,980",527.7
1402,"British Columbia, place of residence",Females,"Total, all causes of death  [A00-Y89]",2019,"18,261",521.7
1403,"British Columbia, place of residence",Females,"Total, all causes of death  [A00-Y89]",2020,"18,747",521.8
1404,"British Columbia, place of residence",Females,"Total, all causes of death  [A00-Y89]",2021,"20,250",555.3
1405,"British Columbia, place of residence",Females,"Total, all causes of death  [A00-Y89]",2022,"20,720",553.8
1406,"British Columbia, place of residence",Females,Salmonella infections  [A01-A02],2018,0,0
1407,"British Columbia, place of residence",Females,Salmonella infections  [A01-A02],2019,0,0
1408,"British Columbia, place of residence",Females,Salmonella infections  [A01-A02],2020,1,0
1409,"British Columbia, place of residence",Females,Salmonella infections  [A01-A02],2021,1,0
1410,"British Columbia, place of residence",Females,Salmonella infections  [A01-A02],2022,1,0
1411,"British Columbia, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2018,0,0
1412,"British Columbia, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2019,0,0
1413,"British Columbia, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2020,0,0
1414,"British Columbia, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2021,0,0
1415,"British Columbia, place of residence",Females,"Shigellosis and amoebiasis  [A03, A06]",2022,0,0
1416,"British Columbia, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2018,43,1.2
1417,"British Columbia, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2019,44,1.2
1418,"British Columbia, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2020,38,1
1419,"British Columbia, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2021,42,1.1
1420,"British Columbia, place of residence",Females,"Certain other intestinal infections  [A04, A07-A09]",2022,44,1.2
1421,"British Columbia, place of residence",Females,Tuberculosis  [A16-A19],2018,7,0.2
1422,"British Columbia, place of residence",Females,Tuberculosis  [A16-A19],2019,2,0.1
1423,"British Columbia, place of residence",Females,Tuberculosis  [A16-A19],2020,6,0.2
1424,"British Columbia, place of residence",Females,Tuberculosis  [A16-A19],2021,9,0.2
1425,"British Columbia, place of residence",Females,Tuberculosis  [A16-A19],2022,7,0.2
1426,"British Columbia, place of residence",Females,Whooping cough  [A37],2018,0,0
1427,"British Columbia, place of residence",Females,Whooping cough  [A37],2019,0,0
1428,"British Columbia, place of residence",Females,Whooping cough  [A37],2020,0,0
1429,"British Columbia, place of residence",Females,Whooping cough  [A37],2021,0,0
1430,"British Columbia, place of residence",Females,Whooping cough  [A37],2022,0,0
1431,"British Columbia, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2018,0,0
1432,"British Columbia, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2019,0,0
1433,"British Columbia, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2020,0,0
1434,"British Columbia, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2021,0,0
1435,"British Columbia, place of residence",Females,"Scarlet fever and erysipelas  [A38, A46]",2022,0,0
1436,"British Columbia, place of residence",Females,Meningococcal infection  [A39],2018,1,0
1437,"British Columbia, place of residence",Females,Meningococcal infection  [A39],2019,1,0
1438,"British Columbia, place of residence",Females,Meningococcal infection  [A39],2020,2,0.1
1439,"British Columbia, place of residence",Females,Meningococcal infection  [A39],2021,0,0
1440,"British Columbia, place of residence",Females,Meningococcal infection  [A39],2022,0,0
1441,"British Columbia, place of residence",Females,Sepsis  [A40-A41],2018,81,2.5
1442,"British Columbia, place of residence",Females,Sepsis  [A40-A41],2019,77,2.2
1443,"British Columbia, place of residence",Females,Sepsis  [A40-A41],2020,97,2.6
1444,"British Columbia, place of residence",Females,Sepsis  [A40-A41],2021,89,2.4
1445,"British Columbia, place of residence",Females,Sepsis  [A40-A41],2022,92,2.3
1446,"British Columbia, place of residence",Females,Syphilis  [A50-A53],2018,2,0.1
1447,"British Columbia, place of residence",Females,Syphilis  [A50-A53],2019,0,0
1448,"British Columbia, place of residence",Females,Syphilis  [A50-A53],2020,0,0
1449,"British Columbia, place of residence",Females,Syphilis  [A50-A53],2021,0,0
1450,"British Columbia, place of residence",Females,Syphilis  [A50-A53],2022,0,0
1451,"British Columbia, place of residence",Females,Acute poliomyelitis  [A80],2018,0,0
1452,"British Columbia, place of residence",Females,Acute poliomyelitis  [A80],2019,0,0
1453,"British Columbia, place of residence",Females,Acute poliomyelitis  [A80],2020,0,0
1454,"British Columbia, place of residence",Females,Acute poliomyelitis  [A80],2021,0,0
1455,"British Columbia, place of residence",Females,Acute poliomyelitis  [A80],2022,0,0
1456,"British Columbia, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2018,0,0
1457,"British Columbia, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2019,0,0
1458,"British Columbia, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2020,0,0
1459,"British Columbia, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2021,0,0
1460,"British Columbia, place of residence",Females,"Arthropod-borne viral encephalitis  [A83-A84, A85.2]",2022,0,0
1461,"British Columbia, place of residence",Females,Measles  [B05],2018,0,0
1462,"British Columbia, place of residence",Females,Measles  [B05],2019,0,0
1463,"British Columbia, place of residence",Females,Measles  [B05],2020,0,0
1464,"British Columbia, place of residence",Females,Measles  [B05],2021,0,0
1465,"British Columbia, place of residence",Females,Measles  [B05],2022,0,0
1466,"British Columbia, place of residence",Females,Viral hepatitis  [B15-B19],2018,27,1
1467,"British Columbia, place of residence",Females,Viral hepatitis  [B15-B19],2019,28,1
1468,"British Columbia, place of residence",Females,Viral hepatitis  [B15-B19],2020,21,0.7
1469,"British Columbia, place of residence",Females,Viral hepatitis  [B15-B19],2021,22,0.7
1470,"British Columbia, place of residence",Females,Viral hepatitis  [B15-B19],2022,17,0.5
1471,"British Columbia, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2018,2,0.1
1472,"British Columbia, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2019,4,0.2
1473,"British Columbia, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2020,1,0
1474,"British Columbia, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2021,3,0.1
1475,"British Columbia, place of residence",Females,Human immunodeficiency virus [HIV] disease  [B20-B24],2022,3,0.1
1476,"British Columbia, place of residence",Females,Malaria  [B50-B54],2018,0,0
1477,"British Columbia, place of residence",Females,Malaria  [B50-B54],2019,0,0
1478,"British Columbia, place of residence",Females,Malaria  [B50-B54],2020,0,0
1479,"British Columbia, place of residence",Females,Malaria  [B50-B54],2021,0,0
1480,"British Columbia, place of residence",Females,Malaria  [B50-B54],2022,0,0
1481,"British Columbia, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2018,48,1.5
1482,"British Columbia, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2019,49,1.5
1483,"British Columbia, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2020,50,1.4
1484,"British Columbia, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2021,54,1.5
1485,"British Columbia, place of residence",Females,Other and unspecified infectious and parasitic diseases and their sequelae 25,2022,70,2
1486,"British Columbia, place of residence",Females,Malignant neoplasms  [C00-C97],2018,"4,757",148.8
1487,"British Columbia, place of residence",Females,Malignant neoplasms  [C00-C97],2019,"4,925",150.1
1488,"British Columbia, place of residence",Females,Malignant neoplasms  [C00-C97],2020,"4,856",143.4
1489,"British Columbia, place of residence",Females,Malignant neoplasms  [C00-C97],2021,"5,149",147.9
1490,"British Columbia, place of residence",Females,Malignant neoplasms  [C00-C97],2022,"5,118",143.1
1491,"British Columbia, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2018,87,2.5
1492,"British Columbia, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2019,89,2.5
1493,"British Columbia, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2020,84,2.4
1494,"British Columbia, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2021,85,2.2
1495,"British Columbia, place of residence",Females,"In situ neoplasms, benign neoplasms and neoplasms of uncertain or unknown behaviour  [D00-D48]",2022,107,2.8
1496,"British Columbia, place of residence",Females,Anaemias  [D50-D64],2018,37,1
1497,"British Columbia, place of residence",Females,Anaemias  [D50-D64],2019,30,0.8
1498,"British Columbia, place of residence",Females,Anaemias  [D50-D64],2020,40,0.9
1499,"British Columbia, place of residence",Females,Anaemias  [D50-D64],2021,43,1
1500,"British Columbia, place of residence",Females,Anaemias  [D50-D64],2022,36,0.9
1501,"British Columbia, place of residence",Females,Diabetes mellitus  [E10-E14],2018,487,14.6
1502,"British Columbia, place of residence",Females,Diabetes mellitus  [E10-E14],2019,464,13.5
1503,"British Columbia, place of residence",Females,Diabetes mellitus  [E10-E14],2020,535,14.9
1504,"British Columbia, place of residence",Females,Diabetes mellitus  [E10-E14],2021,563,15.2
1505,"British Columbia, place of residence",Females,Diabetes mellitus  [E10-E14],2022,533,14.2
1506,"British Columbia, place of residence",Females,Nutritional deficiencies  [E40-E64],2018,18,0.5
1507,"British Columbia, place of residence",Females,Nutritional deficiencies  [E40-E64],2019,11,0.3
1508,"British Columbia, place of residence",Females,Nutritional deficiencies  [E40-E64],2020,15,0.4
1509,"British Columbia, place of residence",Females,Nutritional deficiencies  [E40-E64],2021,18,0.5
1510,"British Columbia, place of residence",Females,Nutritional deficiencies  [E40-E64],2022,13,0.3
1511,"British Columbia, place of residence",Females,"Dementia  [F010-F019, F03]",2018,"1,930",49.7
1512,"British Columbia, place of residence",Females,"Dementia  [F010-F019, F03]",2019,"2,090",52.3
1513,"British Columbia, place of residence",Females,"Dementia  [F010-F019, F03]",2020,"2,011",49.4
1514,"British Columbia, place of residence",Females,"Dementia  [F010-F019, F03]",2021,"2,080",50.3
1515,"British Columbia, place of residence",Females,"Dementia  [F010-F019, F03]",2022,"2,195",52
1516,"British Columbia, place of residence",Females,"Meningitis  [G00, G03]",2018,5,0.2
1517,"British Columbia, place of residence",Females,"Meningitis  [G00, G03]",2019,6,0.2
1518,"British Columbia, place of residence",Females,"Meningitis  [G00, G03]",2020,4,0.1
1519,"British Columbia, place of residence",Females,"Meningitis  [G00, G03]",2021,3,0.1
1520,"British Columbia, place of residence",Females,"Meningitis  [G00, G03]",2022,2,0
1521,"British Columbia, place of residence",Females,Parkinson's disease  [G20-G21],2018,151,4.4
1522,"British Columbia, place of residence",Females,Parkinson's disease  [G20-G21],2019,161,4.7
1523,"British Columbia, place of residence",Females,Parkinson's disease  [G20-G21],2020,211,5.9
1524,"British Columbia, place of residence",Females,Parkinson's disease  [G20-G21],2021,170,4.6
1525,"British Columbia, place of residence",Females,Parkinson's disease  [G20-G21],2022,220,5.8
1526,"British Columbia, place of residence",Females,Alzheimer's disease  [G30],2018,692,18.6
1527,"British Columbia, place of residence",Females,Alzheimer's disease  [G30],2019,714,18.8
1528,"British Columbia, place of residence",Females,Alzheimer's disease  [G30],2020,669,17
1529,"British Columbia, place of residence",Females,Alzheimer's disease  [G30],2021,697,17.3
1530,"British Columbia, place of residence",Females,Alzheimer's disease  [G30],2022,667,16.3
1531,"British Columbia, place of residence",Females,Major cardiovascular diseases  [I00-I78],2018,"4,813",132.2
1532,"British Columbia, place of residence",Females,Major cardiovascular diseases  [I00-I78],2019,"4,780",127.5
1533,"British Columbia, place of residence",Females,Major cardiovascular diseases  [I00-I78],2020,"4,804",125
1534,"British Columbia, place of residence",Females,Major cardiovascular diseases  [I00-I78],2021,"4,863",123.8
1535,"British Columbia, place of residence",Females,Major cardiovascular diseases  [I00-I78],2022,"5,025",126.7
1536,"British Columbia, place of residence",Females,Other disorders of circulatory system  [I80-I99],2018,20,0.6
1537,"British Columbia, place of residence",Females,Other disorders of circulatory system  [I80-I99],2019,18,0.5
1538,"British Columbia, place of residence",Females,Other disorders of circulatory system  [I80-I99],2020,17,0.5
1539,"British Columbia, place of residence",Females,Other disorders of circulatory system  [I80-I99],2021,21,0.6
1540,"British Columbia, place of residence",Females,Other disorders of circulatory system  [I80-I99],2022,19,0.5
1541,"British Columbia, place of residence",Females,Influenza and pneumonia  [J09-J18],2018,479,12.8
1542,"British Columbia, place of residence",Females,Influenza and pneumonia  [J09-J18],2019,404,10.9
1543,"British Columbia, place of residence",Females,Influenza and pneumonia  [J09-J18],2020,313,8.1
1544,"British Columbia, place of residence",Females,Influenza and pneumonia  [J09-J18],2021,235,5.9
1545,"British Columbia, place of residence",Females,Influenza and pneumonia  [J09-J18],2022,302,7.6
1546,"British Columbia, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2018,6,0.1
1547,"British Columbia, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2019,7,0.2
1548,"British Columbia, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2020,4,0.1
1549,"British Columbia, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2021,2,0.1
1550,"British Columbia, place of residence",Females,Other acute lower respiratory infections  [J20-J22],2022,5,0.1
1551,"British Columbia, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2018,849,25
1552,"British Columbia, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2019,854,24.3
1553,"British Columbia, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2020,744,20.4
1554,"British Columbia, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2021,704,18.8
1555,"British Columbia, place of residence",Females,Chronic lower respiratory diseases  [J40-J47],2022,818,21.4
1556,"British Columbia, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2018,2,0.1
1557,"British Columbia, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2019,0,0
1558,"British Columbia, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2020,0,0
1559,"British Columbia, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2021,2,0.1
1560,"British Columbia, place of residence",Females,"Pneumoconioses and chemical effects  [J60-J66, J68]",2022,0,0
1561,"British Columbia, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2018,77,2.1
1562,"British Columbia, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2019,72,1.9
1563,"British Columbia, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2020,71,1.8
1564,"British Columbia, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2021,99,2.5
1565,"British Columbia, place of residence",Females,Pneumonitis due to solids and liquids  [J69],2022,86,2.2
1566,"British Columbia, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2018,190,5.7
1567,"British Columbia, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2019,201,5.9
1568,"British Columbia, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2020,181,5.1
1569,"British Columbia, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2021,165,4.5
1570,"British Columbia, place of residence",Females,"Other diseases of respiratory system  [J00-J06, J30-J39, J67, J70-J98]",2022,210,5.6
1571,"British Columbia, place of residence",Females,Peptic ulcer  [K25-K28],2018,32,1
1572,"British Columbia, place of residence",Females,Peptic ulcer  [K25-K28],2019,29,0.8
1573,"British Columbia, place of residence",Females,Peptic ulcer  [K25-K28],2020,32,0.9
1574,"British Columbia, place of residence",Females,Peptic ulcer  [K25-K28],2021,37,1
1575,"British Columbia, place of residence",Females,Peptic ulcer  [K25-K28],2022,40,1
1576,"British Columbia, place of residence",Females,Diseases of appendix  [K35-K38],2018,4,0.2
1577,"British Columbia, place of residence",Females,Diseases of appendix  [K35-K38],2019,3,0.1
1578,"British Columbia, place of residence",Females,Diseases of appendix  [K35-K38],2020,1,0
1579,"British Columbia, place of residence",Females,Diseases of appendix  [K35-K38],2021,3,0.1
1580,"British Columbia, place of residence",Females,Diseases of appendix  [K35-K38],2022,4,0.1
1581,"British Columbia, place of residence",Females,Hernia  [K40-K46],2018,20,0.5
1582,"British Columbia, place of residence",Females,Hernia  [K40-K46],2019,19,0.5
1583,"British Columbia, place of residence",Females,Hernia  [K40-K46],2020,16,0.4
1584,"British Columbia, place of residence",Females,Hernia  [K40-K46],2021,28,0.7
1585,"British Columbia, place of residence",Females,Hernia  [K40-K46],2022,29,0.8
1586,"British Columbia, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2018,183,6.3
1587,"British Columbia, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2019,203,6.9
1588,"British Columbia, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2020,224,7.6
1589,"British Columbia, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2021,265,8.8
1590,"British Columbia, place of residence",Females,"Chronic liver disease and cirrhosis  [K70, K73-K74]",2022,259,8.2
1591,"British Columbia, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2018,17,0.5
1592,"British Columbia, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2019,33,0.8
1593,"British Columbia, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2020,26,0.7
1594,"British Columbia, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2021,38,1
1595,"British Columbia, place of residence",Females,Cholelithiasis and other disorders of gallbladder  [K80-K82],2022,39,1
1596,"British Columbia, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2018,171,4.7
1597,"British Columbia, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2019,175,4.6
1598,"British Columbia, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2020,199,5.1
1599,"British Columbia, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2021,200,5
1600,"British Columbia, place of residence",Females,"Nephritis, nephrotic syndrome and nephrosis  [N00-N07, N17-N19, N25-N27]",2022,204,5
1601,"British Columbia, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2018,5,0.2
1602,"British Columbia, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2019,9,0.2
1603,"British Columbia, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2020,8,0.2
1604,"British Columbia, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2021,7,0.2
1605,"British Columbia, place of residence",Females,"Infections of kidney  [N10-N12, N13.6, N15.1]",2022,11,0.3
1606,"British Columbia, place of residence",Females,Hyperplasia of prostate  [N40],2018,...,...
1607,"British Columbia, place of residence",Females,Hyperplasia of prostate  [N40],2019,...,...
1608,"British Columbia, place of residence",Females,Hyperplasia of prostate  [N40],2020,...,...
1609,"British Columbia, place of residence",Females,Hyperplasia of prostate  [N40],2021,...,...
1610,"British Columbia, place of residence",Females,Hyperplasia of prostate  [N40],2022,...,...
1611,"British Columbia, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2018,1,0
1612,"British Columbia, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2019,1,0
1613,"British Columbia, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2020,3,0.1
1614,"British Columbia, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2021,5,0.1
1615,"British Columbia, place of residence",Females,Inflammatory diseases of female pelvic organs  [N70-N76],2022,4,0.1
1616,"British Columbia, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2018,3,0.1
1617,"British Columbia, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2019,5,0.2
1618,"British Columbia, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2020,0,0
1619,"British Columbia, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2021,1,0
1620,"British Columbia, place of residence",Females,"Pregnancy, childbirth and the puerperium  [O00-O99]",2022,4,0.1
1621,"British Columbia, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2018,45,2.3
1622,"British Columbia, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2019,39,2
1623,"British Columbia, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2020,41,2.2
1624,"British Columbia, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2021,37,1.9
1625,"British Columbia, place of residence",Females,Certain conditions originating in the perinatal period  [P00-P96],2022,57,3
1626,"British Columbia, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2018,56,2.3
1627,"British Columbia, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2019,49,2
1628,"British Columbia, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2020,58,2.4
1629,"British Columbia, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2021,63,2.5
1630,"British Columbia, place of residence",Females,"Congenital malformations, deformations and chromosomal abnormalities  [Q00-Q99]",2022,60,2.2
1631,"British Columbia, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2018,276,9.6
1632,"British Columbia, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2019,371,12.4
1633,"British Columbia, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2020,933,32.3
1634,"British Columbia, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2021,"1,172",37.7
1635,"British Columbia, place of residence",Females,"Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified  [R00-R99]",2022,952,30.6
1636,"British Columbia, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2018,..,..
1637,"British Columbia, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2019,..,..
1638,"British Columbia, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2020,423,10.9
1639,"British Columbia, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2021,691,19.5
1640,"British Columbia, place of residence",Females,"COVID-19  [U07.1, U07.2, U10.9]",2022,964,24.5
1641,"British Columbia, place of residence",Females,All other diseases (residual) 26,2018,"1,469",43.7
1642,"British Columbia, place of residence",Females,All other diseases (residual) 26,2019,"1,517",44.2
1643,"British Columbia, place of residence",Females,All other diseases (residual) 26,2020,"1,537",43.3
1644,"British Columbia, place of residence",Females,All other diseases (residual) 26,2021,"1,651",45.5
1645,"British Columbia, place of residence",Females,All other diseases (residual) 26,2022,"1,755",46.6
1646,"British Columbia, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2018,727,24.8
1647,"British Columbia, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2019,616,20.1
1648,"British Columbia, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2020,358,10
1649,"British Columbia, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2021,847,26.8
1650,"British Columbia, place of residence",Females,"Accidents (unintentional injuries)  [V01-X59, Y85-Y86]",2022,691,22.2
1651,"British Columbia, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2018,140,5.4
1652,"British Columbia, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2019,141,5.5
1653,"British Columbia, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2020,101,3.8
1654,"British Columbia, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2021,67,2.6
1655,"British Columbia, place of residence",Females,"Intentional self-harm (suicide)  [X60-X84, Y87.0]",2022,43,1.6
1656,"British Columbia, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2018,3,0.1
1657,"British Columbia, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2019,4,0.1
1658,"British Columbia, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2020,2,0.1
1659,"British Columbia, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2021,3,0.1
1660,"British Columbia, place of residence",Females,"Assault (homicide)  [X85-Y09, Y87.1]",2022,0,0
1661,"British Columbia, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2018,0,0
1662,"British Columbia, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2019,0,0
1663,"British Columbia, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2020,0,0
1664,"British Columbia, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2021,0,0
1665,"British Columbia, place of residence",Females,"Legal intervention  [Y35, Y89.0]",2022,0,0
1666,"British Columbia, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2018,10,0.4
1667,"British Columbia, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2019,3,0.1
1668,"British Columbia, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2020,5,0.2
1669,"British Columbia, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2021,6,0.3
1670,"British Columbia, place of residence",Females,"Events of undetermined intent  [Y10-Y34, Y87.2, Y89.9]",2022,6,0.2
1671,"British Columbia, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2018,0,0
1672,"British Columbia, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2019,0,0
1673,"British Columbia, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2020,0,0
1674,"British Columbia, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2021,0,0
1675,"British Columbia, place of residence",Females,"Operations of war and their sequelae  [Y36, Y89.1]",2022,0,0
1676,"British Columbia, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2018,7,0.2
1677,"British Columbia, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2019,13,0.4
1678,"British Columbia, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2020,5,0.2
1679,"British Columbia, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2021,10,0.3
1680,"British Columbia, place of residence",Females,"Complications of medical and surgical care  [Y40-Y84, Y88]",2022,8,0.2
